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Abstract
DAVID PFAEHLER: Electronic Health Records and Health Information Exchange and
Their Impact on International Healthcare System Efficiency
(Under the direction of Dr. Katherine Centellas)
The 19th century epidemiological transition in healthcare caused a major shift in
physician focus from curing one-time, deadly illness to managing chronic disease. Now,
even the most advanced international healthcare systems must find a way to increase their
efficiency in order to compensate for heightened strains on medical systems and swelling
costs of healthcare delivery. Fortunately, recent technological innovation and, chiefly, the
growth of Electronic Health Records (EHRs) provide a potential solution to this looming
threat. EHRs are digital charts with the potential to store and share patient health data
among providers to offer the most informed, streamlined care available. Yet, their
effectiveness in increasing health system efficiency remains uncertain. Relying on the
concept of technical efficiency in the healthcare sector, I explore the efficacy of longterm international EHR implementation. Using OECD data, I performed a Stochastic
Frontier Analysis (SFA) and measured the change in hospital subsector efficiency over
time for each of the 15 chosen countries within my analysis. Followed by this data is a
comprehensive EHR index as well as 5 individual country case studies to better explain
the histories, successes, and failures of EHR implementation throughout the world. These
measures yielded somewhat inconclusive results pertaining to EHR’s effect on
international healthcare efficiency. Nevertheless, the findings of this study strongly
support the need for continued international healthcare efficiency analysis. Rather than
submit to the difficulties of such nuanced and complex analytical processes, researchers
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must remain vigilant and steadfast in their pursuit of efficiency in order to provide
effective, affordable healthcare to everyone in need.
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Chapter One: Introduction
Imagine a world void of waste and procrastination--a world where every resource
was wisely used and seldom wasted. Sure, this idea of maximum efficiency might seem
like a utopian concept, but what if it were realistically achievable? To be efficient is
generally described as the ability to “be capable of producing desired results with little or
no waste (as of time or materials),” (Merriam-Webster, 2020). Efficiency in any walk of
life allows one to do more with less, thus increasing effectiveness, productivity, and
profit. Nations around the globe have been consumed by the idea of increased efficiency
in their governmental systems for quite some time. Over the last several decades,
transportation systems have evolved to move more people over longer distances in
shorter amounts of time and food systems grow produce and livestock bigger and faster
than ever before. Thanks to these developments, invaluable resources--most notably time
and money--have been conserved and society is considerably more productive than it was
just decades ago. These accomplishments in the food and transportation system are
undeniable, but how have more nuanced entities like healthcare systems been modified
and made more efficient over this same period of time?
Many nations have made remarkable improvements to their healthcare systems of
old, attaining higher standards of quality care and spending less money along the way.
These improvements are absolutely necessary as the world’s population continues to
grow older, more overweight and obese, and significantly more likely to be diagnosed
with chronic conditions and diseases that require frequent visits to healthcare facilities.
One might ask how these countries have managed to accomplish this challenging task of
reforming their outdated healthcare systems, but the answer that continues to reappear in

Pfaehler 8
each of these situations is not quite as complex as one might think: technological
innovation.
There have been numerous recent technological innovations that have improved
the efficiency of healthcare systems. These innovations use groundbreaking software to
make the most of the resources they have available--whether human or financial.
Suddenly, a medical discovery that once required millions of dollars in funding now only
requires a fraction of the cost. Better yet, a physician that could only care for several
hundred patients a week can now effectively treat thousands. Artificial intelligence,
virtual reality simulations, and three-dimensional printers are just a handful of a
seemingly endless number of cutting-edge innovations that have helped healthcare
professionals improve their quality of care--but have electronic health records (EHRs)
and health information exchange (HIE) had a similar impact on healthcare professionals
and the systems in which they work?
Electronic health records are defined as “a longitudinal electronic record of
patient health information generated by one or more encounters in any care delivery
setting. Included in this information are patient demographics, progress notes, problems,
medications, vital signs, past medical history, immunizations, laboratory data, and
radiology reports,” (Menachemi, 2011, p. 48). Some of the basic benefits associated with
the use of EHRs include easy access of computerized records and the elimination of poor
penmanship. Additionally, three functionalities of EHRs that hold great promise in
improving quality of care and reducing cost are clinical decision support (CDS) tools,
computerized physician order entry (CPOE) systems, and health information exchange
(HIE) capabilities (Menachemi, 2011). These dynamic functions certainly paint digital
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patient charts in an attractive light, but EHRs have also faced their fair share of criticism
from those skeptical about their practicality in modern healthcare settings. While health
information technology can operate in useful ways and promote more efficient systems, it
can also be expensive, difficult to implement effectively, and even lead to burnout among
healthcare workers (Brown, 2019). As the need for more intelligent and flexible
healthcare systems continues to grow, it is imperative to determine whether EHR and
HIE truly help enhance efficiency within medical care settings.
This task of defining efficiency can be a difficult undertaking for any sector of the
economy. Even more so, defining efficiency in the health sector and within the context of
EHR and HIE conjures an entirely new layer of nuance and subjectivity. Each and every
health system--regardless of the country--varies greatly and is uniquely challenging to
measure. The majority of efficiency studies of healthcare systems rarely conform to
production-line overviews in which a set of clearly identifiable inputs is used to produce
a standard type of output. Instead, health care is designed to meet the specific needs of an
individual patient, with various circumstances, preferences, and needs--ultimately leading
to considerable variation in how inputs are consumed and outputs are produced. The
unfortunate reality is that health systems are extremely complex and there is often no
consensus on which countries perform most efficiently, which method is the most
appropriate, or which health outcomes should be directly attributed to certain healthcare
inputs. Therefore, it is easy to understand that measuring efficiency within healthcare
systems comes with serious obstacles in comprehending how systems function, evolve,
and ultimately rank.
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Yet, in an era characterized by cloud computing breakthroughs and pressures to
digitize patient data for increased coordination, it makes sense now more than ever that
electronic versions of a patient’s paper chart could be a tool that many healthcare systems
should be able and willing to implement in order to improve their system efficiency-especially as global health trends shift unfavorably towards populations that are
increasingly old, obese, and chronically ill. This reality alone illustrates an immense need
for effective, interoperable, streamlined care that can increase efficiency by limiting the
amount of inputs a system must consume in order to arrive at a certain output level. In
fact, many countries have already taken the leap on this front and, although the
implementation of a health information exchange network is relatively new, this
technology has emerged as a promising agent for improving the quality and reducing the
cost of healthcare systems for many inquisitive nations aspiring for increased efficiency.
In the following chapters, the idea of utilizing EHR and HIE systems to increase
health system efficiency is explored in more detail. We first begin by illustrating the
modern need for more efficient healthcare delivery and the efficacy of EHR
implementation. Next, we shift to the importance, methodology, and challenges of
analyses involving international healthcare system efficiency. Afterwards, a
comprehensive data analysis is utilized to provide an efficiency score for each of the
fifteen countries within question. These scores are then compared over various time
periods depending on each nation’s EHR implementation date. Finally, case studies for
five separate countries are provided to shed further light onto the real-life successes,
failures, and intricacies of EHR and HIE implementation. All of this is done with the
hope of gaining a more precise understanding of not only whether EHRs have affected
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international health system efficiency, but also at what point, to what degree, and in what
aspects.
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Chapter Two: History and Background
Epidemiological Shift: Illnesses Turn Chronic
Before exploring the efficacy of new technological tools in healthcare such as the
electronic health record and health information exchange, it is first important to explain
the sequence of events that have brought about the need for such innovations. Similar to
any other branch of science, medicine has changed considerably over the last several
centuries--and almost exclusively for the better. However, with these advances also came
an equal share of unforeseen challenges.
Premodern medicine began in the western world of ancient Greece as a once
fundamentally intuitive branch of knowledge. Good physicians were thought to enter the
world as natural-born caretakers--literally being predestined to enter the healing arts in a
way of thinking that more closely resembled religion than science. However, in the early
1500s premodern medical practice gradually dissolved and physicians began to
modernize their caretaking process into a practice more consistent with what we see
today. Human beings increasingly saw themselves as distinct and exceptional within the
natural order of things and began their pursuit of conquering nature and the challenges it
posed.
This growth of science and technology fueled the idea that human ingenuity could
and should harness and control the risks of the natural environment. Enlightenment
metaphysicians like René Descartes expanded upon these ideas by developing new
theories based on mechanistic physiological philosophies--the idea that animal (and thus,
human) bodies are machines, constituted by material mechanisms, and governed by the
laws of matter alone (Stanford, 2014). Robert Boyle, largely regarded as the first modern
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chemist, furthered this neoteric belief through his work by treating patients with various
drugs which targeted particular illnesses and conditions. Boyle even attested that he was
more knowledgeable and effective in treating patients than were the era’s physicians
(Shapin, 2000). This newly established idea of nature as a studiable and controllable
entity gave rise to medical thinking in the West that became increasingly dominated by a
human responsibility to cure, manage risk and predictability, and focus on material
objects and empirical processes.
Healthcare, like premodern physician practice, experienced a similar evolution
from a process of caring at homes; avoiding physiological examination; and thinking
deeply and intuitively about realigning divining imbalances to a modern process of caring
for patients in hospitals or office buildings; analytically calculating cases; and
quarantining patients in order to maximize efficiency in a factory-like production. Just as
the world economy began to flourish and crystallize--stressing the need for standardized
processes to ensure consistency among the workforce--so, too, did global healthcare
practices require an increasingly reliable and adaptable systemization of healthcare
delivery.
As this modernization took shape and physicians found creative ways to cure onetime, life-threatening illnesses, patients also found themselves increasingly inflected with
more nuanced, difficult-to-manage diseases. In the 19th century, the major causes of
mortality were typically infectious diseases like pneumonia, tuberculosis, and
gastrointestinal infections (Tippett, 2014). Thankfully, these conditions are largely
eradicated today thanks to the development of antibiotics, vaccinations, sewage
management systems, and improved education regarding sanitation and food handling.
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Among the most important of these discoveries are the Germ Theory of Disease proposed
by Louis Pasteur in the late 1800s and the Broad Street Pump Experiment conducted by
John Snow in 1854. These revelations proved that pathogens and outbreaks could be
studied, treated, and cured. And--while exceptionally beneficial for society as a whole-the adverse effect of these breakthroughs is that a large part of modern clinical practice
concerns the long-term management of disease, with no focus on cure. This evolution
from one-time illnesses to chronic diseases is known today by public health experts as the
epidemiological shift.
Trends tend to show that as life expectancy reaches an unprecedented high of 70+
years, heart disease, cancer, and stroke replace infection as prime killers (Hinote, 2017).
Even more worrisome is the fact that this burden of chronic disease is increasing
worldwide. In high-income countries, chronic diseases have long been the leading causes
of death and disability; and more than 70% of deaths globally are due to chronic diseases.
In the United States, that statistic increases to more than 87% (Barrett, 2016)--although it
should be stated that the global pandemic induced by the recent outbreak of the novel
coronavirus COVID-19 may cause 2020 to deviate from this long-standing trend.
Nevertheless, chronic diseases consistently and directly affect overall health care budgets,
employee productivity, and economies. These diseases account for two-thirds of the
overall disease burden in middle-income countries and are expected to rise to threequarters by 2030--often in parallel with economic development, ironically (Barrett,
2016). Even deaths from smoking are expected to increase dramatically in low-income
countries over this same period. In the 20th century, tobacco-use killed around 100
million people worldwide. In the 21st century, an estimated one billion will die
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prematurely--a tenfold increase. By 2030, more than 80% of deaths attributable to
tobacco will be in low-income countries (CDC, 2012).
Our world’s healthcare systems have neglected the threat of chronic disease for
far too long. We are now entering an era that will pose countless strains on healthcare
budgets and public health. As more and more patients find themselves diagnosed with
chronic diseases like cancer, diabetes, and heart disease, it becomes clear that the
epidemiological transition from one-time illnesses to chronic diseases has produced a
world population that is less healthy and more at risk today than it was just decades ago.
This infamous transition has been exceptionally costly--not only from the perspective of
dollars, but, more importantly, lives--and our health systems must continue to adapt and
evolve if we wish to continue to treat patients effectively in the future. EHR and HIE, an
innovative healthcare tool that has shown promising signs of increasing the efficiency of
healthcare delivery, is a potential solution to this daunting problem.
Rising Healthcare Costs
Finding a way to improve care for populations that grow increasingly chronically
ill and in need of frequent medical attention is a daunting task, but the difficulty of
finding ways to pay for this new standard of care is equally as concerning. In the past,
patients were frequently diagnosed with diseases that could be cured with relatively little
care and cost. A physician could enter the room and, within minutes, administer a shot or
prescribe a medication that would relieve the patient’s malady for good (Hinote, 2017).
However, chronic illnesses like diabetes, heart disease, and cancer require long-term care
that is exponentially more costly and often focuses on managing illness rather than curing
it entirely. Health experts have highlighted the increase in spending associated with this

Pfaehler 16
epidemiological shift, especially in the United States. In 2019, researchers from Johns
Hopkins University found that health spending in the U.S. has been growing faster than
other OECD countries in spite of efforts to control spending in the U.S. Their study
revealed that overall U.S. health spending increased at an average rate of 2.8 percent
annually between 2000 and 2016, which is greater than the OECD median annual
increase of 2.6 percent. During that time, inflation-adjusted spending per capita on
pharmaceuticals also increased much more quickly in the U.S. with an increase rate of
3.8 percent per year compared to just 1.1 percent for the OECD median (JHU, 2019).
These statistics are worrisome for a United States healthcare system that maintains one of
the most expensive and least equitable systems among high-income countries. However,
despite the validity of these statistics, there is an overarching trend of increased
healthcare costs globally that is not exclusive to just the United States and this alarming
development poses numerous international problems.
The 2018 World Health Organization (WHO)’s global health financing report
revealed that spending on health is growing faster than the rest of the global economy,
accounting for 10% of global gross domestic product (GDP). This trend shows a swift
upward trajectory of global health spending, which is particularly noticeable in low- and
middle-income countries where health spending is growing on average at 6% annually
compared with a 4% increase for high-income countries (WHO, 2019). These economic
trends are often obscured by countries with healthcare systems that control prices to
lower individual patient expenditure and blunt the effects of rising healthcare costs.
Prescription drug price negotiation in Germany is an example of this occurrence. Prices
are established through collective negotiations between a single buyer (representing the
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insurers) and a single seller (the drug maker). Strong public and political pressure usually
deter gridlock and encourage the two sides to come to an agreement--but if negotiations
halt, the drug’s price is established by an arbitration panel with representatives from each
side and an appointed chair.
While governmental actions like price controls may be situationally effective in
keeping costs low for individual patients, they contribute to exacerbated problems in
other areas of healthcare. Britain’s National Health Service (NHS) demonstrates how
price controls can severely hinder the performance of a healthcare system by not only
veiling the reality of increased cost of care, but also creating problems like long wait
times and limited patient access to treatment. According to a recent report from the Royal
College of Surgeons, nearly a quarter of a million British patients have been waiting over
six months to receive planned medical treatment from the NHS and more than 36,000 of
those individuals have been in treatment queues for nine months or more (Pipes, 2019).
Even more concerning is that patients in dire need of care are given few options for
affordable care as “the target for treating cancer patients within 62 days of urgent GP
referral has not been met for over 5 years,” (Thorlby, 2019). Unfortunately, issues with
price-controlled healthcare systems do not stop in Britain. Hospitals in Japan have seen
their cost of care limited so aggressively that almost all hospitals operate in a large
deficit. Similarly, German physicians and other health professionals have unified and
protested for increased salaries as they feel they are not adequately compensated for their
work due to their country’s heavily regulated healthcare industry.
It is imperative that one understands the differences associated with the function
of healthcare systems around the globe. The way in which each nation utilizes their
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healthcare system is important, but even more so in the context of rising healthcare costs
is analyzing how a country publicizes their healthcare data. In a healthcare system like
that of the United States, which avoids regulating prices and redistributing costs from
patient to patient, the rise of healthcare cost over the last few decades is unmistakable.
However, countries that blunt the effects of rising costs through negotiations and
distribution of the burden of cost over millions of citizens make these trends less evident.
Nevertheless, as expressed by the WHO’s 2018 report, spending on health is increasing at
a faster rate than any country’s economy can continue to endure. This trend exacerbates
the need for timely change in healthcare at the international level--change as widespread
as it is effective. In the near future, we must find a way to redefine our healthcare systems
in order to improve care for aging populations that are increasingly plagued by chronic
illnesses. Even more importantly, we must achieve this goal through a method that
reduces cost and ensures the long-term sustainability of affordable healthcare
internationally.
The Past, Present, and Future of Electronic Health Record Use
Documenting a patient’s medical history and capturing this information within a
preserved record is an idea that originated long ago. In fact, translation of ancient
Egyptian hieroglyphic inscriptions and papyri from 1,600-3,000 BC indicate the use of
medical records thousands of years before even premodern medicine began to take shape
(Evans, 2016). Despite this longstanding history of patient data collection, the utilization
of medical records has drastically changed over the last century--and with this change
have come new facilitators, barriers, and unknowns associated with EHR use. Until the
1920s, paper medical records were sparsely used within healthcare practices. However,
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by the 1960s and 1970s, a technological boom of computers and data processors quickly
laid the foundation for traditionally paper charts maintained in folders to be transformed
into hybrid patient charts using paper records and electronic records, known today as the
Electronic Health Record. The last several decades have been revolutionary for the EHR
and Health Information Exchange (HIE) as a whole, but there remains some uncertainty
about their ability to increase efficiency in modern healthcare systems.
In 1992, the state of EHRs experienced profound changes thanks to affordable
hardware, powerful and compact personal computers, and accelerated internet access.
Suddenly, what was once a hybridization of paper and computerized data began to shift
entirely electronic. As a result, academic centers began developing more functional EHR
systems and clinical use skyrocketed. Medical professionals started to implement EHRs
to quickly access physician notes, orders, consults, laboratory results, and more. Before
long, Clinical Decision Support (CDS)--a technology designed to provide physicians and
other health professionals with assistance with clinical decision-making tasks--and
Computerized Provider Order Entry (CPOE)--the process of entering and sending
treatment instructions via computer applications rather than paper, fax, etc.--were added
to the list of possible EHR operations that further improved healthcare processes. These
tools soon became two of the most important benefits associated with EHR use
(Menachemi, 2011).
Since 1992, the modern era has continued to advance and expand upon the
Electronic Health Record. After it became obvious that a standard communicative
language between EHR systems was needed, Health Level Seven (HL7)--an international
standard for transfer of clinical and administrative data--was developed and began to

Pfaehler 20
facilitate the interfacing of multiple EHR systems. Strides towards interoperability-interfacing on a larger scale and between more systems--also took shape as large private
vendors and governments alike began to invest in improving the capabilities, functions,
and fluidity of EHR systems. As of 2015, EHRs are now created, used, edited, and
viewed by multiple independent entities including primary care physicians, hospitals,
insurance companies, and patients (Evans, 2016). As one author states, “They [EHRs]
have changed the dynamics of the patient-clinician interaction,” (Evans, 2016) through
clinician-patient email, virtual consults, and telemedicine.
Outside of these dynamic changes, financial savings are another positive impact
associated with modern EHRs. Potential yearly savings from a reduction in the
maintenance cost of paper medical records in the U.S. alone are estimated at $1.3 billion
with cumulative savings of $19.9 billion over 15 years. Likewise, the cumulative
potential net efficiency and safety savings from hospital systems could be nearly $371
billion with potential cumulative savings from physician practice electronic medical
records (EMRs)1 at nearly $142 billion. This estimation is calculated based on efficiency
savings only; the potential net financial benefit could double if the health savings
produced by chronic disease prevention and management were also included (Hillestad,
2005). Ambulatory systems also stand to benefit with savings estimated at $11 billion
over the same period (Kumar, 2010).
Given these positive developments, it is clear that the EHR has become more
accomplished and versatile as technology has continued to adapt and evolve. This reality

1

Unlike EHRs, which include detailed patient medical history and have the potential to share this
information with other providers, EMRs (Electronic Medical Records) contain only a single practice’s
digital health chart.
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has led to a number of innovations and possibilities, but it has also brought about
legitimate barriers and concerns. Among the top three barriers associated with EHR
implementation are missing data/data error, no standards, and a loss of productivity
(Kruse, 2018). One scholar details the challenges of health information technology (HIT)
adoption, stressing that “we cannot yet design and deploy complex software systems that
are on time, within budget, meet the specific requirements, satisfy their users, are reliable
(bug free and available), maintainable, and safe,” (Karsh, 2010, pg. 617). Furthermore,
even with recent strides towards interoperability, nations have been reluctant to assume
wide scale adoption of the technology, a step that is absolutely necessary in order to
utilize all available benefits of an interconnected and efficient EHR system.
More concerning for the outlook of wide scale EHR implementation is one
author’s recent observational study which refutes the common belief that EHR
implementation is associated with gains in measures of inpatient mortality, readmissions,
and patient safety indicators (PSIs) (Yanamadala, 2016). In fact, data from this study of
patients receiving medical and surgical care at various EHR and non-EHR system
hospitals suggests that EHR implementation may actually increase the amount of time
spent necessary to care for patients during clinic visits, thus contributing to clinic
inefficiency. While more time with each patient may be desirable to some, this extra time
was more frequently spent inputting redundant information than it was spent actually
caring for the patient. Yanamadala’s article is certainly concerning for proponents of
EHRs who believe federal incentives are necessary to further propagate the benefits
experienced by wide scale EHR implementation. Instead of justifying calls for increased
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federal funding, this article insists that the associated barriers may be more challenging to
overcome than initially thought.
Even with incredible technological advancements, perhaps the most daunting
challenges facing the future of EHR implementation is its potential to become too
knowledgeable to the point of invading personal privacy. After all, newfound technology
provides EHR systems with the potential to utilize digital pathology and other
sophisticated tools to manage and integrate data, laboratory results, voice recognition,
barcodes, and documentation templates. Similarly, increased hardware capacity allows
for entire family health histories to be entered into the EHR. Used in conjunction with
big-time data and text mining, health professionals have found ways to analyze outcomes,
patterns, temporal trends, and correlations within families to improve both private and
public health outcomes. Even the human genome has since been decoded, sequenced, and
stored within modern EHR systems (Evans, 2016). These advancements are some of the
loftiest goals for techno-optimists, but they also seriously increase anxieties about the
security and protection of medical histories and physician-patient confidentiality.
Nonetheless, proponents of HIE continue to develop more fluid and capable EHR
systems and there exists a number of ingenious yet attainable expectations for EHR
technology over the next quarter century.
The ability of applications like the electronic health record to communicate,
interpret, and act intelligently upon complex healthcare information is just one of a
number of aggressive expectations for the progression of EHR systems in the future. Yet,
while EHR and HIE has evolved considerably over the last several decades, it is more
important for current EHRs to continue to meet the needs of modern medicine’s
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distributed systems and rapidly changing healthcare environment rather than attempt to
reinvent the wheel. The fundamental role and purpose of electronic health records in the
future will be:
“...a data repository based on international standard APIs [Application
Programming Interfaces] for the retrieval and storage of data. It will be coupled
with facility and vendor provided, and user selected applications for data review
and entry and especially CDS. In addition to health data, social, economic,
behavioral, and environmental data will play a vital role in providing and
especially improving healthcare. The applications will be interchangeable, not
dependent on EHR versions and updates, and will facilitate innovation like the
current Smart Phone applications,” (Evans, 2016, p. S56).
If EHRs prove capable of effectively managing these increased functions, HIE as a whole
should expect to bolster a number of design improvements and enhanced capabilities in
the future. Among these changes could be EHRs with: improved interoperability,
increased use of cloud technology, longitudinal (birth to death) focuses, big data storage,
internationally accepted standards, foreign language translations with preserved clinical
meanings, and flexible systems (Evans, 2016). Each of these functions, both the mundane
and the ambitious, should be shaped by experienced clinicians with a vested interest in
the functionality and efficiency of the future EHRs.
Of course, current and future EHRs will continue to have the potential to increase
medical errors if used improperly; therefore, as these systems continue to change over
time and improve, engineering and reengineering will be needed in order to increase their
potential benefit while at the same time improving their safety. EHR safety concerns
involving unsafe technology and unsafe use will persist in the future, but the focus of this
issue remains on finding solutions to prospective errors rather than systemwide
punishment of electronic health records and health information exchange. Modern data
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and scholarly sentiment support the continued adoption of EHR and HIE within various
healthcare systems; although, a continuation of current research on the impact of EHR
and HIE will continue to prove beneficial in determining whether wide scale
implementation should be incentivized or scrapped.
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Chapter Three: Identifying Efficiency within Healthcare Systems
Why is Healthcare Efficiency Important?
The study of health sector efficiency and related issues such as cost, effectiveness,
and value for money are some of the most important dimensions of healthcare
performance. These statistics portray the extent to which inputs to the health system are
used to secure valued health system goals. In almost every other area of the economy,
consumer preferences ensure that the most valued outputs are produced at market prices.
However, all too often, this same balance is not upheld in the health sector which causes
market failures and leads to dysfunction, poor quality, and inappropriate care. Health care
financiers including governments, insurers, and households are interested in knowing
which systems, providers, and treatments contribute the largest health gains in relation to
the level of resources they consume. Especially concerning is the long-term financial
sustainability of a number of different health resources and social safety net systems. In
order to change the unfortunate reality of healthcare system dysfunction, the study and
pursuit of efficiency should be the central objective of all parties invested in a highfunctioning, healthy society and state. To achieve this goal, the study of healthcare
efficiency is essential and, to that end, better instruments for measuring and
understanding efficiency are absolute necessities (Cylus, 2016).
Understanding Efficiency and Inefficiency
Inextricably tied to healthcare efficiency--and efficiency in general--is the idea of
inefficiency. As easily as resources can be utilized wisely, they can likewise be wasted
foolishly. Tackling unwise resource allocation has an important accountability value as it
is essential to reassure health system backers, patients, and the general population that
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their money is being spent wisely and that resources are allocated optimally. These two
concepts of efficiency and inefficiency may seem beguilingly simple. After all, these
measures are frequently defined as a simple ratio of resources consumed to some measure
of outputs that they create. Yet, despite its apparent simplicity, applying these concepts of
efficiency in real-world settings can give rise to considerable complexity. This is
especially true when examining efficiency in relation to the health system. All too often,
measuring efficiency in this context reveals a number of complicated and interlinked
processes which are difficult to evaluate and deem to be efficient or inefficient. In
working with these concepts, it is helpful to start small, explain what efficiency and
inefficiency mean in a certain context, and continue to expand upon an understanding of
efficiency from this point. The following paragraph begins this process by outlining two
very important terms in this field of research: allocative efficiency and technical
efficiency.
Processes in the health system may be identified as inefficient for two distinct, but
related reasons. The first reason is that health system inputs such as expenditure or other
resources may be directed towards outputs that are not viewed as priorities by society.
For example, high-cost end-of-life cancer treatments may be beneficial for the individuals
involved, but society may see this spending as generally wasteful and believe that it could
be better spent elsewhere (Cylus, 2016). Economists refer to this concept as allocative
efficiency (AE) and it is often quantified using the measure of quality-adjusted life years
(QALYs) as a prime cost-effectiveness criterion for determining treatment. The second
reason for inefficiency within health systems is that there could be a misuse of inputs in
the process of producing valued health system outputs, leading to wasteful spending. An
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example of this can be viewed with unnecessary duplications of patient medical tests that
squander resources which could potentially be utilized more effectively elsewhere
(Cylus, 2016). Economists refer to this concept as technical efficiency (TE). These
comparative measures essentially indicate whether or not an entity is maximizing its
outputs given a certain level of inputs. However, where AE is concerned with analyzing
strategic choices of what outputs to produce or what inputs to consume, the prime interest
of TE is in the operational performance of the entity. While these two forms of
inefficiency may be different in their approaches, each of their analyses of health system
performance is intended to offer insights into the success with which health system
resources are transformed into physical outputs (i.e. patient consultations) or valued
outcomes (i.e. improved health).
An Analytical Framework for Thinking about Efficiency Indicators
Now that the principles of AE and TE have been identified and explained, a
simplistic viewpoint of efficiency can be established. Adopted from the European
Observatory on Health Systems and Policies’ 2016 “Health System Efficiency'' Report,
Figure 3.1 below represents the ratio of inputs an organization consumes in relation to
the valued outputs it produces (Cylus, 2016, p. 10).
Figure 3.1: The naive view of efficiency
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In this model, efficiency is determined using an economist’s “production function”
mindset. A “production function” mindset is an economist’s view of the transformation
of inputs into valued outputs. This mindset indicates the maximum feasible level of
output for a given set of inputs. Within this thought process, any failure to attain that
maximum efficiency level is to some degree an indication of inefficiency. While
straightforward and easy to follow, this way of thinking represents nothing more than a
partial measure of efficiency because the indicator shows only a fragment of the complete
transformation of resources into the desired outputs.
Especially when measuring health care systems, the majority of outputs rarely
conforms to a production-line type technology in which a set of clearly identifiable
outputs is used to produce a standard type of output. Instead, health care is designed to
meet the specific needs of an individual patient, with various circumstances, preferences,
and needs--ultimately leading to considerable variation in how inputs are consumed and
outputs are produced. In light of these complexities, it is necessary to provide a
framework for thinking more clearly about specific efficiency indicators and the respects
in which each indicator may be informative, misleading, or partial. The five aspects of
any efficiency indicator are: 1) the entity to be assessed; 2) the outputs (or outcomes)
under consideration; 3) the inputs under consideration; 4) the external influences on
attainment; and 5) the links with the rest of the health system (Cylus, 2016, p. 11).
The beginning of an efficiency assessment first depends on establishing the
boundaries of the entity under scrutiny. At one extreme, an analysis could be as micro as
a single treatment. At the other extreme, an analysis could be as macro as an entire health
system. Most often, however, efficiency measurement takes place somewhere in the
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middle, where the actions of individuals or groups of practitioners, hospitals, or other
organizations within the health system are to be analyzed and assessed. Despite this
variation, almost all efficiency analyses rely on comparison--whether between entities or
within a single entity for a certain time period. This means that it is of extreme
importance that the entities being compared are legitimately similar. Efficiency
comparison between a popular clothing firm and an internet start-up, a large hospital and
a small primary clinic, and a country like the United States and that of Comoros--a
volcanic archipelago off Africa’s east coast--is to some extent unfavorable and
suboptimal.
From this point, two fundamental issues need to be considered concerning the
outputs under consideration within the efficiency analysis--specifically in regards to how
these outputs should be defined and valued. It is most often agreed that health care
outputs should be defined in terms of the health gains produced. These health gains are
evidenced in a number of ways, but most often through diminishing rates of mortality,
increasing rates of discharge, and more removed statistics like upturns in life expectancy.
However, given the lack of routine information gathering and the challenging operational
realities of this consensus, outputs are often defined in a different manner. In practice,
analysts are often constrained to measuring efficiency on the basis of measures of
activities. These measurements are frequently represented in the form of patients treated,
operations undertaken, or outpatients seen. These general values are somewhat
inadequate because they fail to capture the specificity, diversity, and quality of health
care delivery, but there is not yet a viable alternative to using such measures.
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Fortunately, determining the inputs under consideration within efficiency metrics
is less problematic because they can be accurately measured and summarized in the form
of costs. Nevertheless, even these agreed-upon measures can yield conceptual and
practical difficulties. A fundamental decision that determines these difficulties is the level
of disaggregation among the specified inputs. At one extreme, a single measure of
aggregate inputs (in the form of total costs) can be used. The input side of efficiency then
effectively becomes costs. This approach assumes that the entities under scrutiny are free
to deploy inputs efficiently. However, in practice, some aspects of input deployment are
beyond the control of the entity and can only be changed in the longer-term. This
discrepancy leads to a misassessment of inputs for one or more of the entities. A similar
but opposite issue occurs with labor inputs that can often be over-aggregated by different
labor types depending on the circumstance (Cylus, 2016).
These difficulties continue with inputs of capital whose misuse can be a major
source of inefficiency. Yet, incorporating these measures of capital into analyses is
challenging, rudimentary, and sometimes misleading. In practice, analysts often have to
be ready to resort to very crude measures of inputs such as the number of hospital beds or
floor space as a proxy for physical capital. In deciding which inputs should be under
consideration, it is important to remember that all efficiency metrics should be developed
according to the intentions of the analysis. Doing so helps to remedy some of the
aforementioned issues. If the interest is in the narrow and short-term use of existing
resources, then disaggregating inputs is advantageous to the analysis as a whole. If the
interest is in a less constrained and longer-term analysis, then a single measure of total
costs may be perfectly adequate for indicating the physical inputs of an entity.
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After satisfying these three aspects that make up what is considered a naive view
of efficiency, it is important to consider two separate classes of factors that bolster
efficiency analyses to make them more complete and comprehensive. One of which--the
external determinants of performance--affects organizational capacity by influencing an
entity beyond its control in the environment in which it must operate. These
environmental factors include, but are not limited to, the severity of the disease of the
patient, primary care organization structure, and local geography and settlement patterns
(Cylus, 2016). There is often considerable debate as to what environmental factors are
considered controllable and which should be included within an efficiency analysis. In
the short-term, almost all input factors and external constraints should be fixed. In the
longer-term, many can be changed depending on the level of autonomy. In many
circumstances, it may be appropriate to consider efficiency metrics both with and without
adjustment for external factors.
Rounding out the last aspect of any necessary efficiency indicator is the need to
consider an analysis’ links with the rest of the health system. This task is essential to
develop a more complete efficiency analysis model. Scrutiny of a health system entity in
isolation may ignore the important implications of the entity’s impact on whole system
efficiency. For example, if a primary care practice is held to account by only metrics of
cost per patient, it might improve efficiency by shifting costs to other agencies without
actually making better use of available resources (Cylus, 2016). This reality should be
accounted for in any assessment of efficiency and, in principle, it should be feasible to do
within the analytic framework. However, this is rarely done in practice and consequently
important for determining bias in efficiency assessment.
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Unfortunately, it is almost impossible to completely and perfectly accommodate
each of the aspects summarized above into a single efficiency metric. Regardless, it
remains important for efficiency analysts to be aware of which factors are more likely to
affect the integrity of the analysis as a whole and seek to offer guidance on the
implications of serious omissions and weaknesses (Cylus, 2016). This framework, in
accordance with countless others, embraces the challenges and imperfections of
efficiency analysis, aiming to deconstruct efficiency metrics into a manageable number of
issues to propagate future research rather than remain incapable of potential efficiency
comparison. Figure 3.2 below summarizes and expands upon the more simplistic
understanding of efficiency demonstrated previously by Figure 3.1. Similar to Figure
3.1, this table was adopted from the European Observatory on Health Systems and
Policies’ 2016 “Health System Efficiency'' Report (Cylus, 2016, p. 19), but provides a
more complete and complex understanding of efficiency which may be used for
comprehensive efficiency metric analyses.
Figure 3.2: A more complete model of efficiency
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Measuring Efficiency: Methods and Limitations
As mentioned previously, technical efficiency and allocative efficiency are
essential for understanding inefficiency as they measure wastes of resources in their own
distinct, but related manners. TE indicates whether an organization is maximizing its
outputs given its chosen level of inputs, regardless of the value placed on those outputs,
but AE indicates whether the value of the chosen outputs creates the maximum value to
society. These economic concepts, despite their seeming complexity, offer the only
current available unifying framework for assessing all the diverse objectives of health
systems within an efficiency framework (Cylus, 2016). There are numerous metrics that
utilize these economic concepts within their methodology to measure efficiency, but
among the most common and established of these methods are Data Envelopment
Analysis (DEA) and Stochastic Frontier Analysis (SFA). In fact, “Over 400 published
applications have used these methods within health care settings over the past 30 years,”
(Hollingsworth, 2016, p. 99). Both methods see efficiency as a simple relationship
between inputs consumed and outputs produced and assess how effectively a unit of
production, such as a hospital, uses its own inputs, such as staff and drugs, to produce
outputs, such as patients treated. These analyses are especially important in the context of
international healthcare efficiency because they provide perhaps the most reputable
framework based on sound economic concepts and contribute transparent and potentially
useful efficiency comparisons.
In efficiency analyses, the main interest is typically the connection between inputs
and outputs, and often the connection between costs and outcomes. DEA is a useful
efficiency metric for researchers that makes use of linear programming methods to place
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weights on the inputs and outputs in order to measure how efficiently an entity is
converting inputs consumed to outputs produced. Measurements using DEA typically
show the entities in question in the best possible light. This favorable representation
should be taken into account when trying to understand the outcomes of a DEA analysis.
For a multiple output or multiple input firm--like a hospital treating different types of
cases using numerous nurses and physicians, various equipment, and so on--an overall
measure of a hospital’s TE requires summing these different inputs and outputs in some
way. In other words, we must give weights to each of the inputs and outputs. Final
efficiency measurements using DEA analysis metrics typically fall between 0 and 1,
demonstrating the TE score for each entity. DEA is also potentially useful in measuring
efficiency changes over time, often referred to as a Malmquist Index. Measuring changes
over time, rather than simply providing a snapshot of efficiency, gives a more accurate
picture of what is really happening across time from entity to entity (Hollingsworth,
2016).
Despite its potential successes, DEA analysis also has its fair share of
shortcomings. The technique is deterministic and outlying observations are very
important in determining the efficiency frontier--the threshold of entities that offer the
highest expected return on inputs for a defined level of outputs. Therefore, when using
DEA it is imperative to ensure like comparison between entities so as not to grossly
misrepresent the outliers within question and skew the efficiency frontier generated by
the metric (Hollingsworth, 2016). Similarly, DEA is sensitive to the number of input and
output variables used in the analysis. Overestimates of efficiency scores can occur if the
number of units relative to the number of variables used is small. Thus, a general rule of
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thumb as determined by the EOHSP is that “the number of units used should be at least
three times the combined number of input and output variables,” (Hollingsworth, 2016, p.
104). Still, DEA remains by far the most common method for analyzing efficiency within
healthcare settings as it has now been applied successfully hundreds of times within such
contexts.
Similar to DEA, SFA is a useful metric for researchers that uses its own
methodology to measure the distance an entity such as a hospital is from a calculated
efficiency frontier. However, rather than using mathematical programming, SFA uses a
statistical regression analysis to complete such a task. In SFA, the usual statistical error
term utilized in analogous regression equations is split into both inefficiency and error.
Some view this distinction as a more precise measure of efficiency as it accounts for
statistical noise--random irregularity researchers find in any real-life data (Hollingsworth,
2016). These advantages, along with recent advances in modeling techniques and
computing capabilities, are part of the reason why the use of SFA has received increased
attention in the production of health care analyses over recent years. Nevertheless, as
with DEA and every other known method of efficiency analysis, there are several
downfalls. Estimating the production frontier of an SFA analysis requires all outputs-such as cost, for example--to be meaningfully aggregated in a single measure. However,
this mix between variables and producer characteristics can skew distribution, error
terms, and ultimately lead to an over- or under-estimation of efficiency (Hollingsworth,
2016).
Adding to the complexity of efficiency analyses is the brutal reality that even the
most respected analyses like DEA and SFA can be very challenging in an international
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context. This is due in part to the seemingly endless variations across data sources and
key differences in health system structures and practices. Even when this data is readily
available, it can be extremely difficult to find compromises within the data that work to
allow effective cross-country comparability. However, as mentioned in the EOHSP’s
2016 health system efficiency report, it is:
“almost certainly preferable to steer the health system with imperfect measures
we have available, rather than to fly blind. In our view, efficiency analysis should
be routinely embedded in all relevant functions of service delivery and
policymaking. However, it is vital that decisions are taken in full recognition of
the strengths and weaknesses of indicators, and that the search for improved
metrics and better resources for comparison is pursued with vigour” (Cylus, 2016,
p. 19).
In fact, any potential metric of efficiency will have its limitations depending upon its
framework. This should not intimidate us as researchers, but instead motivate us to
improve our measures and continue to analyze the efficiency of healthcare systems.
Especially in an international context, these studies are severely lacking which in-turn
limits proposals of policies that are potentially beneficial for benchmarking and gauging
the efficiency of different types of healthcare delivery. These policies have the potential
to remedy struggling healthcare systems and improve the lives of the citizens who rely on
them; yet they continue to be overlooked. In fact, a study highlighted by EOHSP shared a
2008 review finding that out of all health care efficiency studies, only 4% were crosscountry analyses (Cylus, 2016). Despite recognition that such data are desirable to
capture trends in efficiency, compare changes over time, and identify the causal effects of
policies, there simply remains reluctance among researchers to attempt to compare the
limited cross-country longitudinal health data currently available.
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Reconciling these truths--the difficulties of studying efficiency, the limitations
associated with international healthcare comparisons, and the emergence of promising
analytical metrics such as DEA and SFA--is a challenging but necessary task if
researchers and governments alike wish to improve the current understanding of
healthcare efficiency. Even more so, as worldwide populations continue to grow and
resources continue to diminish, there is an increasing need for every country to maximize
their overall effectiveness in healthcare delivery. The unfortunate reality is that health
systems are extremely complex and there is often no consensus on which countries
perform most efficiently, which method is the most appropriate, or which health
outcomes should be directly attributed to certain healthcare inputs. Nonetheless, it is for
the same reason that the most highly valued metrics are those which allow at least
somewhat valid comparisons across countries (Cylus, 2016, p. 159).
In a perfect world, of course it would be prudent for countries to focus more on
harmonizing and improving access to registry or hospital discharge level data. This is true
not only at the micro level, but also at the macro level because it would allow for the
control of potential confounders and ensure comparison across entities that are
undoubtedly similar. It would be even more advantageous if countries could provide
longitudinal data that allowed researchers to track changes in efficiency across time
(Cylus, 2016). Sadly, these resources and databases simply are not available to us--at
least not yet. Although, as data sources continue to gradually improve internationally, “it
is only a matter of time when register-based monitoring will be a part of routine reporting
and follow-up of the performance, effectiveness and efficiency of providers,” (Sund,
2016, p. 73). Technical developments could likewise help to facilitate data availability in
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the near future, but even without these advances the appeal of international comparisons
of health care efficiency is clear--despite the many challenges. Until that time,
researchers should focus less on trying to develop perfect models and instead focus on
robust comparisons using multiple analytical approaches.
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Chapter Four: Measuring International Healthcare System Efficiency
Establishing a Comprehensive Framework for International Efficiency Analysis
In the previous chapter, the five aspects of any efficiency indicator are outlined in
detail. In every efficiency analysis, it is important to remember that we must identify: 1)
the entity to be assessed; 2) the outputs (or outcomes) under consideration; 3) the inputs
under consideration; 4) the external influences on attainment; and 5) the links with the
rest of the health system (Cylus, 2016, p. 11). In the case of healthcare efficiency
analyses, we must be even more precise and consistent in our identification of these
varying parameters. Each of these aspects must be outlined--whether measuring
healthcare efficiency within the context of EHR and HIE or within another context-before beginning analysis in order to provide a clear and specific framework on which
each efficiency indicator can be judged as informative, misleading, or partial.
Any analysis begins by establishing the boundaries of the entity under scrutiny.
This entity could be as micro as a single treatment or as macro as an entire health system.
For the purposes of this analysis, data will be measured from the perspective of an entire
health system and on a country-by-country basis. This type of analysis focuses on entire
health statistics databases such as the World Bank, World Health Organization, United
Nations, and--in this instance--the Organization for Economic Cooperation and
Development (OECD). However, analysis of these health system entities--and thus the
databases that measure them--will predominantly focus on efficiency within the context
of the hospital sector within each given country. Therefore, a hybrid approach is assumed
in this analysis with a focus on hospital care to combine the benefits of the OECD’s
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reliable data with the advantages of statistically significant findings associated with
subsector-level analysis approaches.
The reason for this hybrid approach is due to the benefits and limitations
associated with using DEA, SFA, or any other analysis metric in the context of healthcare
efficiency. Employing these analyses with an emphasis on cross-country databases or a
focus on system- or subsector-level approaches requires an understanding of how these
analyses will stand in terms of internal validity, external validity, precision measurement,
etc. Similar to analytic frontier methods--data analyses that establish a threshold of
entities that offer the highest expected return on the inputs consumed--the factors behind
these concentrations are nuanced and only increase in complexity when employed to
measure efficiency internationally. To simplify the various qualities of analyses
conducted with cross-country, system-, and subsector-level approaches, Table 4.1
provides a summary of the examples, benefits, and limitations associated with each. This
table is a shortened adaptation of its original version which can be found in the European
Observatory on Health Systems and Policies’ 2016 “Health System Efficiency'' Report
(Cylus, 2016, p. 160).
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Table 4.1: Summary table of international efficiency indicators

Using this table, we can establish and outline our analysis as an international
comparison of the technical efficiency and productivity of the hospital subsector. Having
now clearly identified the entity in question, it is imperative to identify the countries that
will be measured under such a framework. For the purpose of this research project, the
efficiency study assumes a fifteen-country analysis. This dataset should provide an
extensive look into healthcare system efficiency for each country and serve as a
resourceful tool for future researchers. These countries in question are: Australia, Canada,
Denmark, France, Germany, Israel, Italy, Japan, Netherlands, New Zealand, Norway,
Sweden, Switzerland, United Kingdom, and the United States. This analysis should be
completed without making disparate or inappropriate comparisons across countries as
each of these nations is comparatively modernized and industrialized with health systems
that are unique, diverse, and rather high functioning. Any two of these fifteen countries
could be chosen at random and compared to the other with little difficulty as each
maintains a similar quality of life, economic development, health expenditure, and much
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more. More importantly, each of these countries holds membership in the OECD and
continuously updates database profiles that contain countless insights into the operational
capacity of their respective healthcare systems. Finally, while the number of countries
considered within the analysis could be increased to include other highly developed
OECD nations, we instead chose to limit the number of countries to only OECD member
states with well-documented histories of EHR and HIE implementation. Much of this
history was provided thanks to The Commonwealth Fund’s International Health Care
System Profiles in which each of the fifteen countries selected are included.
Now that boundaries have been established for the entity and respective countries
under consideration, two fundamental issues need to be carefully considered regarding
the outputs associated with the analysis. It is most often agreed that health care outputs
should be defined in terms of the health gains produced. However, this health gain data is
almost never readily available which prompts researchers to instead use inpatient days or
discharges as an intermediate form of output data. This analysis will focus on data
pertaining to two of the most readily available intermediate outputs: discharge and
mortality. Discharge rate is generally important because it documents how many
individuals are successfully moving through the health system. More specifically,
heightened discharge rates in the presence of EHR and HIE could be an indication that
the technology is increasing a hospital sector’s capacity to treat more patients more
quickly, thus increasing overall efficiency. The output of discharges is favored over
inpatient days as unnecessary inpatient days may be a false indication of high hospital
efficiency (Varabyova, 2013). For the purposes of this research project, discharge data is
considered by diagnostic category, measured by density per 100,000 members of the
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population, and includes all diagnostic category causes. Mortality, the second health care
output taken into consideration, captures the average in-hospital mortality rate as an
additional variable to control for the potential tradeoff between inefficiency and death.
Opposite to discharge rate, mortality rates are important because they provide
information about how many individuals are unsuccessfully moving through the health
system. This measurement represents a viable measure for hospital quality because it
encompasses “effective medical interventions and [the] timely and coordinated treatment
of patients,” (Varabyova, 2013, p. 74). Within this analysis, the in-hospital mortality
output is maintained and measures the value in terms of rate per 100,000 hospital
patients. Oftentimes, a lack of routine information gathering and the challenge of arriving
at a consensus of output measurements in question poses problems for efficiency
analyses, but these two outputs under consideration are commonly adopted within a
number of current healthcare efficiency studies.
The next phase of analysis turns to determining the inputs in question. These
choices are less problematic within efficiency metrics because they are almost always
accurately measured and summarized in the form of resource costs. At one extreme, a
single measure of aggregate inputs (in the form of total costs) can be used. However, in
this analysis the input variable of cost is adapted to accommodate a number of different
common hospital resources: number of beds, total hospital employment, physician
employment, and professional nurse and midwife employment. First, the number of
hospital beds represents a measure of total hospital resources consumed. The number of
beds is “conventionally used as an approximation for the capital and technology input in
a within-country hospital comparison as well as in an international context,” (Varabyova,
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2013, p. 74). Next, total hospital employment represents a head count of available
medical personnel within a given hospital. This data is sometimes disaggregated by skill
level--especially to differentiate between the availability of physicians or nurses and
midwives--but total hospital employment remains a necessary input measurement to
account for healthcare systems and entities that stray away from healthcare delivery via
traditional hospital personnel. Nevertheless, given this analysis’ focus on OECD database
metrics, physician employment as well as professional nurse and midwife employment
are both considered as separate variables to deliver a more complete count of total inputs
into each hospital-sector-focused measurement.
Our analysis has now satisfied three aspects of what typically make up a naive
view of efficiency: the entities, outputs, and inputs under consideration (pictured in
Figure 3.1 of Chapter Three). Now, we must also consider two separate classes of factors
that enhance the validity of any efficiency analysis. One of these factors, the external
determinants of performance frequently referred to as environmental variables, affects
organizational capacity by influencing an entity beyond its control in its operational
environment. These environmental variables often include disease severity of each
patient, primary care organization structure, and local geography and settlement patterns.
For the purpose of this international efficiency measure, the analysis will include:
healthcare expenditure, financing of health care, income inequality, market influences,
education, length of stay, health status, patient mix, and full-time employment.
The first of these external factors, healthcare expenditure, is absolutely necessary
to measure as this data provides insight into not only what portion of the economy is
dedicated to health funding, but also whether this dedicated funding is effectively
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improving healthcare system performance to justify the cost. This measure is included in
environmental variables and not input variables because it is not directly involved in the
care delivery process in the same manner as total hospital beds, total hospital
employment, etc. Instead, this variable is beyond the control of a hospital’s operational
environment. In this study, healthcare expenditure is measured in terms of share of gross
domestic product and includes all facets of spending--both public and private--in order to
tailor the measurement to each country’s economy.
Financing of health care is similarly important for complete and comprehensive
analyses, especially because all OECD countries use different methods of financing their
healthcare through both public and private sources. An analysis can control the effects of
this mixed financing scheme by considering both the percentage of public and private
financing. As mentioned by Varabyova, high levels of private spending can often lead to
regressive health systems and lead to greater inequalities in health resource access (2013,
p. 74). This analysis measures both of these financing methods separately, but in different
ways due to limitations in data availability. Public financing is measured using the share
of gross domestic product consumed by curative and rehabilitative care in hospital
settings. On the other hand, private financing is measured using the share of current
expenditure on health for voluntary schemes or out-of-pocket payment schemes. The
units of measurements for the two variables of healthcare expenditure and financing of
health care may appear to be different at first glance, but the second measure simply
provides a more concentrated view of how current health expenditure is divided between
public and private outlets.
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The third environmental variable considered is income inequality because
differences in income distribution “might affect health status and health care efficiency at
the international as well as at the regional level,” (Varabyova, 2013, p. 74). This variable
is recorded using the Gini coefficient which assumes a value from 0 to 1 in which a
higher value represents a greater degree of inequality.
Market influences are likewise included to account for competitive pressures
within the health sector that could elicit faster adoption of technology or better capture
economies of scale. These influences are typically measured using total hospital density
as well as public hospital density to again emphasize the importance of considering
mixed-scheme financing. Within the analysis, each of these measures are maintained and
counted in terms of density per million population.
The remaining environmental variables to be measured are equally as important
for consideration within international healthcare efficiency analyses but differ slightly
from those previously described as they focus more on country demographics and
population health statistics. Education represents one of these variables and has proved to
be a key contributing factor to empirical studies on health, influencing both quality of life
and mortality rates (Varabyova, 2013, p. 74). As is common, this analysis measures
education as the percentage of the population with a secondary education ages 25 to 64.
Length of stay within hospital settings also represents another factor that differs
considerably from country to country. Certain health systems may be structured so that
hospital stays are less costly than others which allows providers to keep patients longer
without fear of high expenses; this reality may lead to unnecessary inpatient days and a
disproportionate increase in inefficiency. To help eliminate some of this nuance, average
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length of stay for all causes is measured in days and included in the analysis. Health
status is yet another measure that controls for the heterogeneity in population health
status. Therefore, life expectancy is measured in years to characterize the quality of
elderly care. On the other hand, infant mortality rate is measured in deaths per 1000 live
births to assess the quality of prenatal care.
The factor of patient mix is then included to continue with this demographic
focus. Case-mix differences are almost always evident within empirical studies and
hospital analyses should include some measure of the proportion of elderly patients. In
this analysis, such a proportion is quantified by measuring the percentage of the total
population 65 years old and older. Finally, full-time employment is included as the last of
the environmental variables to account for what could be an overestimation of part-time
labor input. This analysis takes into consideration the share of full-time employment in
each country’s economy to control for the difference in working hours from one OECD
country to the next.
An analysis that satisfies each of these four aspects of efficiency indication
provides a more complete view of efficiency. This is important within any efficiency
analysis, but absolutely imperative for the validity of studies which aim to compare
international healthcare systems. If any of these aspects differ to a considerable extent-the entity in question, input variables, output variables, or environmental variables-researchers will inevitably face difficulties in formulating reliable comparisons. Even
having satisfied each of these components, yet another aspect must still be considered to
provide an even more polished efficiency analysis model: the links an analysis shares
with the rest of the health system. This aspect is important because scrutiny of a health

Pfaehler 48
system entity in isolation has the potential to ignore the important implications of the
entity’s impact on whole system efficiency. In principle, this aspect of analysis should be
feasible to do within a given framework. An in-depth evaluation of health system
operations within the context of EHR and HIE is provided in Chapter Six for several
different countries. However, for the purposes of this research project, the analysis
provided bypasses hyper-specific scrutiny of whole system efficiency to instead utilize a
hybrid approach that focuses on subsector-based data made available by cross-country
databases like the OECD.
Measuring Efficiency within the Context of EHR and HIE
As evidenced by preceding sections and chapters of this text, measuring
efficiency from country to country is an extremely beneficial skill and useful tool for
healthcare researchers, workers, and beneficiaries. To be able to measure efficiency
within and between healthcare systems provides researchers with the insight they need to
improve regional, national, and international care delivery. However, this understanding
efficiency means very little in the context of this research project if it cannot be applied
within the context of electronic health records and health information exchange.
In order to accomplish this task, I performed a data analysis--more specifically, a
stochastic frontier analysis--over a period of 18 years (2000 to 2017) to determine
efficiency scores for each country and year. Efficiency scores were then compared on a
country-by-country basis using the year that EHRs were introduced and the most current
efficiency score available (2017). In almost all cases, there is no exact point in time when
EHRs were introduced on a nationwide scale for a given country. Current literature
exemplifies the slow-moving nature of EHRs thanks to high cost, reluctant adoptance,
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and challenges in effective training and use so it is understandable that these initial dates
of EHR implementation are somewhat fluid and open to educated interpretation. To
accommodate for this obstacle, an estimated date was determined for each country. These
dates, along with indexes of EHR adoption by country and extended explanations for how
each date and index score was selected, are provided in more detail in Table 5.5 of
Chapter Five.
By comparing these efficiency scores through numerous time periods and across
various countries, the hope is to gain a more precise understanding of not only whether
EHRs have affected health system efficiency, but also at what point, to what degree, and
in what aspects. This method represents the most inclusive analysis of EHR and HIE
impact on international healthcare system efficiency. Efficiency analyses--and the scores
that they determine--control for the majority of outside variables that might otherwise
tarnish a study with bias. Comparing these values over time should provide a more telling
representation of the impact EHRs have on each nation and the international community
as a whole.
Limitations: Methods
There are countless obstacles to measuring and understanding the complex
functions of healthcare and various healthcare systems, but one thing is absolutely
certain: our methods can always be updated and improved. In a more perfect analysis,
one might improve some of the variables under consideration--like disaggregating
discharge data to classify discharges by diagnostic category. In doing so, this output
could be made more extensive by including a shortlist of diagnostic categories or a global
length of stay (LOS) measure. However, given the limitations of this research project, a
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luxury such as this had to be sacrificed. In a perfect world, it would undoubtedly be
prudent to focus on harmonizing data or going the extra mile to control for potential
confounders. Sadly, this reality is not always attainable, but that does not discount the
versatility and usefulness of methods such as this. In the future, developments in
healthcare and economic research could help to facilitate new frameworks for thinking
about and analyzing healthcare system efficiency--especially as it relates to new tools
provided by HIE such as the EHR--but even without these advances this methodology
has proved itself both thoughtful and extensive. As mentioned previously, it is less
important for researchers to focus on trying to develop perfect models and more
important to instead focus on robust comparisons using diverse analytical approaches and
deliberate thought processes.
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Chapter Five: Data and Analysis
Justification for a Hybrid Stochastic Frontier Analysis (SFA) Approach
In Chapter Four, Table 4.1 provides a summary of a number of different
approaches for international efficiency measurements. Each of these examples--crosscountry, system-, and subsector-level approaches--brings its fair share of benefits and
limitations to any efficiency measurement. For the purpose of this project, the following
analysis combines different aspects of each of these approaches into a hybrid approach to
create a more valid and reliable assessment of international efficiency. This hybrid
analysis uses cross-country data from the OECD iLibrary Data Warehouse but does so
with a system-level focus on hospital sector data to calculate an efficiency score for each
country under consideration. The purpose of this mixed analysis is to combine the
advantages of each type of approach and avoid some of the methods’ associated
disadvantages. Advantages of this hybrid approach include: regularly-updated, reliable,
and comprehensive data; the capacity to control for confounding variables to some
extent; and the ability to effectively compare entire health systems. Likewise, some
disadvantages this analysis tries to bypass include: weak associations between inputs,
outputs, and expenditures; limited external validity; and an impeded focus on health
outcomes as opposed to an assessment of health outputs.
This hybrid approach to international efficiency measurement and the data
associated with each of the inputs, outputs, and environmental variables under
consideration is then regressed using Stochastic Frontier Analysis (SFA) in order to both
understand how each input affects an associated output and to determine an overall
efficiency score for each country. SFA was determined more appropriate than Data
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Envelopment Analysis (DEA) for several reasons. First, DEA focuses on often
complicated linear programming methods that must place weights on certain inputs and
outputs. On the other hand, SFA uses statistical regression methods that combine all
variables into a single aggregate measure. Additionally, SFA measures relationships
between variables in ways that are often regarded as more user-friendly and easily
understandable. An example of this is denoted in the Findings portion of this chapter as
associated coefficients show the extent to which both the inputs and environmental
variables affect each output. The last--and perhaps most influential--reason for choosing
SFA over DEA was the availability of online resources and research professionals to help
assist in completing such an analysis. Simply put, SFA appeared more appropriate for the
purposes of this study.
The analysis portion of this research project was conducted using STATA, a
general-purpose statistical software package most often used for research in the fields of
economics, sociology, political science, biomedicine, and epidemiology (Stata, n.d.). I
was instructed on how to use this software package for basic regression analyses,
conducting t-tests, extrapolating graphs and charts, etc. in one of my undergraduate
courses. However, given the hyper-specific nature of DEA and SFA analyses as well as
their importance in this area of study, I thought it best to reach out to several
professionals for assistance in completing my efficiency analysis. After several
unsuccessful attempts to locate and secure assistance from faculty, I solicited the help of
a third-party postdoctoral researcher who aided my completion of the SFA analysis.
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Findings: Output 1
Table 5.1 and Table 5.3 show the results of this analysis as each table presents
the Input and Environmental Variables’ coefficient scores in relation to Output 1 and
Output 2. Similarly, Table 5.2 and Table 5.4 represent efficiency scores for each country
in relation to Output 1 and Output 2. These efficiency scores represent technical
efficiency benchmarks where 1.000 is completely efficient (more favorable) and 0.000 is
completely inefficient (least favorable). The Do Files used to inform these STATA
commands can be located in the Appendix chapter. The findings resulting from this data
analysis using these commands are found below. Again, the results of Output 1 are
important because discharge rate more or less documents how many individuals are
successfully moving through the health system. In the case of EHR and HIE, heightened
discharge rates could be an indication that the technology is increasing a hospital sector’s
capacity to treat more patients more quickly, thus increasing overall efficiency.
Table 5.1: Stochastic Frontier Analysis Coefficients, Output 1
Stochastic Frontier Analysis
Output 1: Log Discharge Rate By Diagnostic Category, All Causes
(Per 100,000 Population)
VARIABLES

COEFFICIENT

INPUTS
1)

Total hospital beds (per 1000 pop.)

0.081***

2)

Total hospital employment (per 1000 pop.)

-0.012***

3)

Physicians employed in hospitals (per 1000 pop.)

0.154***
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4)

Professional nurses and midwives employed (per 1000 pop.)

-0.004***

ENVIRONMENTAL VARIABLES
1)

Health expenditure (share of GDP)

0.006

2)

Expenditure on curative and rehabilitative care (share of GDP)

0.064

3)

Household out-of-pocket payments (share of health exp.)

4)

Income inequality (Gini coeff.)

4.335***

5)

Total hospitals (per million pop.)

0.007***

6)

Publicly owned hospitals (per million pop.)

-0.002

7)

Upper secondary education (per 1000 pop.)

-0.000

8)

Average length of stay, all causes (days)

0.054***

9)

65 years old and over (% of total pop.)

-0.020***

10)

Life expectancy at birth (years)

-0.022

11)

Infant mortality (deaths per 1000 live births)

-0.071*

12)

Incidence of full-time employment (share)

-0.004

-0.005*

Notes: ***Significant at the 1% level; *Significant at the 10% level

When working with data analysis of any type, one factor is always important in
determining the validity of a given set of results: statistical significance. As evidenced by
the table above, all four input variables were found statistically significant in influencing
Output 1, the discharge rate. Given this information, we can confidently move on to
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analyzing our coefficient score to better understand how each of these variables
influences Output 1. Examining the coefficient score for Input 1, one can resolve that if
the total number of hospital beds increases by 1 bed per 1000 population, the discharge
rate increases by .081 discharges per 100K population. Likewise, if the number of
physicians employed increases by 1 physician per 1000 population, the discharge rate
increases by .154 discharges per 100K population. However, one can also conclude that
the total hospital employment and the number of nurses and midwives employed decrease
the discharge rate significantly. While this only occurs to a very marginal degree, (.012
and .004, respectively) this information is still meaningful in determining how one
variable impacts another. Switching focus to the environmental variables, one can
conclude that income inequality, total hospitals, and average length of stay each
significantly influence efficiency in a positive manner (by 4.335, 0.007, and 0.054
coefficient points respectively). On the other hand, a higher proportion of older people
and a higher infant mortality seem to reduce efficiency (by 0.020 and 0.071 coefficient
points, respectively). Meanwhile, other variables such as the number of total hospitals is
significant at the 10% level. While this determination may still influence our view of how
certain variables impact the rate of discharges or the overall efficiency, it is not
economically meaningful.
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Table 5.2: Efficiency Scores by Country and Year, Output 1

Table 5.2 provides efficiency scores for each of the countries under consideration
for any given year between 2000 and 2017. In cases where efficiency scores are missing,
it is due to a lack of data available to complete the statistical regression. This data is most
often lacking in the Input category but is occasionally absent for environmental variables
as well. This hindrance is explained in more detail in the Limitations section of this
chapter. Nevertheless, it appears as though both the United States and Norway exhibit the
highest overall efficiency scores for any country examined within the analysis--although,
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it is important to note that the last seven years are missing efficiency measures for the
United States. Therefore, it remains somewhat unclear whether the United States can be
viewed as more efficient than Norway, Israel, or a handful of other countries within the
analysis. Additionally, it is remarkable that several countries achieved a maximum
efficiency score of 1.000 and were considered at the benchmark efficiency level for
healthcare efficiency over any extended period of time. However, given the number of
efficiency scores missing within this portion of the analysis, it can be concluded that the
measure possesses a rather weak validity.
Findings: Output 2
Table 5.3 was arranged using the same methods as Table 5.1. Thus, the values
found within this table can be interpreted in a similar manner. The only difference worthy
of notation for interpreting these coefficient scores is the switch from Output 1,
measuring the discharge rate, to Output 2, measuring the average in-hospital mortality
rate.
Table 5.3: Stochastic Frontier Analysis Coefficients, Output 2
Stochastic Frontier Analysis
Output 2: Log Average In-Hospital Mortality Rate
(Per 100,000 Patients)
VARIABLES

COEFFICIENT

INPUTS
1)

Total hospital beds (per 1000 pop.)

2)

Total hospital employment (per 1000 pop.)

0.013***
-0.003
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3)

Physicians employed in hospitals (per 1000 pop.)

4)

Professional nurses and midwives employed (per 1000 pop.)

-0.128***
0.022**

ENVIRONMENTAL VARIABLES
1)

Health expenditure (share of GDP)

-0.000

2)

Expenditure on curative and rehabilitative care (share of GDP)

-0.000

3)

Household out-of-pocket payments (share of health exp.)

-0.000

4)

Income inequality (Gini coeff.)

5)

Total hospitals (per million pop.)

0.000*

6)

Publicly owned hospitals (per million pop.)

0.000

7)

Upper secondary education (per 1000 pop.)

-0.000

8)

Average length of stay, all causes (days)

9)

65 years old and over (% of total pop.)

10)

Life expectancy at birth (years)

-0.000***

11)

Infant mortality (deaths per 1000 live births)

-0.000**

12)

Incidence of full-time employment (share)

0.000***

-0.000***
0.000*

0.000

Notes. ***Significant at the 1% level; **Significant at the 5% level; *Significant at the 10% level.

As evidenced by the table above, the number of hospital beds and the number of
physicians employed significantly influence the average in-hospital mortality rate. If the
total number of hospital beds increases by 1 bed per 1000 population, the mortality rate
increases by .013 mortalities per 100K population. However, if the number of physicians
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employed increases by 1 physician per 1000 population, the mortality rate decreases by
0.128 mortalities per 100K population. Therefore, investing in human resources in
hospitals such as physicians employed is very important. Unfortunately, when we
observe relationships among the environmental variables, it is clear that the analysis does
not hold the same internal validity as that of Output 1--and it is less likely to maintain any
sort of external validity. This low level of internal validity is likely due to large
collinearity, missing values, and an overall low sample size of panel data available.
Ultimately, while some of these input and environmental variables are found to be
significant, none of them are economically meaningful at the three decimal point level.

Table 5.4: Efficiency Scores by Country and Year, Output 2

The abundance of variables exhibiting almost no correlation displayed within the
findings of Table 5.3 forecast the rather meaningless efficiency scores provided in Table
5.4. These efficiency scores do not differ at all at the three decimal point level. While
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they do differ at lower levels, this variation is almost completely insignificant. It is clear
that the efficiency analysis for this outcome is neither statistically nor economically
meaningful. A detailed explanation for this adverse outcome is provided in the
Limitations section below.
Findings: Efficiency Scores in the Context of EHR and HIE
Given the unfavorable results highlighted in Table 5.4 of this data analysis,
measurement of the effects of EHR and HIE on international healthcare system efficiency
will proceed using only the efficiency scores found in Table 5.2. Of course, as mentioned
previously, these effects will be calculated by measuring the change in efficiency over
time for each of the countries under consideration. The first date used in measuring the
difference in efficiency scores will be determined using the initial date of EHR program
or legislation implementation in each country. Therefore, this date will vary by country
and may be open to interpretation in certain circumstances. The second date used in
measuring the difference in efficiency scores remains fixed for the year 2017--the most
up-to-date efficiency score capable of being measured given available OECD data. Each
of the initial dates for EHR implementation for each respective country is outlined in
Table 5.5 below. In addition to this date, the table provides the respective name of the
EHR program or legislation as well as an index score for each country. Similar to the task
of determining the initial date of EHR implementation, the index score is determined in a
manner that is somewhat open to interpretation. However, justifications for each score are
provided within the table. Each of these decisions were informed by current literature as
well as an assessment of current EHR adoption relative to other countries considered
within the analysis.
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Table 5.5: EHR Index, Implementation, and Adoption by Country
Countries

Date of
Name of EHR
Implementation Program/Legislation

Reasoning for Index Score

Australia

2012

My Health Record

➢ Currently beginning opt-out due to security
concerns

Canada*

2001

Infoway

➢ Lacking adoption in hospitals

Denmark

2007

E-Journal

➢ Does not exist as a national EHR, but instead as
a means of data empowerment

France*

1998

Carte Vitale

➢ High interoperability, adequate adoption rates,
and plans to extend to social sector in the future

Germany

2004

EHC, GMG

➢ Does not exist as an EHR, but instead as a smart
card

Israel

2012

Italy

2012

Japan*

2002

Netherlands

2011

AORTA

➢ Plans to grow eHealth programs continue to
remain in developmental stages

New Zealand

1980

Health Information
Platform (HIP)

➢ Four regional systems that operate
independently without interoperability

Norway

2008

Summary Care
Record (SCR)

➢ History of high adoption, usage, and consistent
improvement

Sweden

2009

National Patient
Summary (NPÖ)

➢ All 21 regions have provided citizens with access
to a national EHR since EHR was adopted

Switzerland

2015

LCIP

➢ Recently implemented with anticipation of slow
adoption

United
Kingdom*

2015

NHS App

➢ EHR abandoned early, patient record now
linked only through NHS App

HITECH Act

➢ Development of Meaningful Use standards,
eightfold increase in use since EHR
establishment

United
States*

2009

➢ Strong implementation with plans for increased
interoperability

-

➢ Average implementation with plans to slowly
connect interregional EHRs

InFSE

➢ Very little progress in implementing a nonexperimental national EHR

-

Notes: *Countries outlined in Chapter Six: Case Studies by Country; Legend located below.
Very Strong
Implementation

Strong
Implementation

Average
Implementation

Weak
Implementation

Very Weak
Implementation
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Now that each country has an identified date of initial EHR program or legislation
implementation, the efficiency change over time can be measured and analyzed. The
results for this calculation are provided in Table 5.6 below.
Table 5.6: Change in Efficiency Over Time

These results are admittedly suboptimal in the grand scheme of determining the
long-term effect that EHRs and HIE have on international healthcare system efficiency.
Of the results, two of the countries--France and Germany--show positive increases in
efficiencies over an 18- and 14-year time period, respectively. Conversely, six of the
countries--Denmark, Israel, Italy, Netherlands, Norway, and Switzerland--demonstrate
negative declines in their efficiencies with an average time period of almost 8 years
between EHR implementation and current modern-day use. The remaining countries
under consideration--Australia, Canada, Japan, New Zealand, Sweden, the United
Kingdom, and the United States--all remain undetermined in terms of measuring their
change in efficiency over time. Two of these nations--Canada and the United States--
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provided a handful of efficiency scores over the 2000 to 2017 time period, but each of the
other countries yielded no results for any of the years in question. Explanations for these
deficiencies are outlined in the following section and Chapter Seven. However, this data
analysis seems to raise more questions about both the long-term efficacy of EHRs and the
feasibility of performing international healthcare efficiency analyses than it does affirm
optimistic sentiments about health information technology as a whole.
Limitations: Findings
There are a number of limitations that could and should be addressed in an
analysis such as this to improve its validity and comprehensiveness for the future. One
can begin at the very beginning with the difficulties in measuring a rather new topic such
as electronic health records and health information exchange. As with any new
technology, there are limitations in measuring when it was implemented, to what degree,
and to what level of success. Even more complicated is the fact that the idea of EHR
implementation has been an issue that numerous countries have wrestled over for years.
Some countries have even moved forward with EHR implementation for a number of
years before deciding to abandon the program entirely--an example of this action is
touched on and explained in detail in Chapter Six with the case of the United Kingdom.
Continuing on with the limitations of this data analysis, it is important to think
back again on the limitations of efficiency study in the first place. There is almost no
consensus on how exactly it should be carried out, which entities should be included, or
what variables should be under consideration. Even more troubling is the prospect of
conducting an efficiency analysis from an international perspective where even more
challenges and nuance begin to intertwine with each step of the analysis. Countries must
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be proven--at least to some degree--demographically, politically, and economically
similar. Without satisfying this requirement, the data input into any analysis can be
skewed or tarnished with bias altogether.
If each of these fundamental prerequisites are satisfied, the most insurmountable
obstacle of them all--data availability and collection--waits in the wings for researchers to
battle fruitlessly. Data availability and collection are impediments that researchers must
deal with in almost every investigative or analytical scenario, but even more so in the
case of international analyses of healthcare and healthcare efficiency. Data sources are
often numerous, but frequently lack comprehensive longitudinal data for even a third of
the countries around the globe that could otherwise be more appropriately studied and
understood. When this data is rarely available, it almost never satisfies the needs of
programs that demand thousands of observations in order to determine causality, prove
statistical significance, and yield acceptable standard deviations. For example, even in the
case of Output 1, which provided the most significant results of this analysis, there
remain a myriad of missing values in the dataset. As a result, more than a third of the
available efficiency scores are missing within this study--and five of these countries are
missing scores in their entirety.
Even when these countries and a majority of their input, output, and
environmental variables are accounted for and reported, there still remains a serious
statistical issue of small sample size. Statistical regressions, especially those of the more
complex variety like SFA and DEA, rely on large sample sizes in order to calculate
statistically significant values like the coefficient and efficiency scores. In the case of this
analysis, 15 countries were measured using 4 input variables, 2 output variables, and 12

Pfaehler 65
environmental variables over an 18 year period (2000-2017). Altogether, these variables
numbered more than 270 unique observations. Even with somewhat large sects of
missing data, no variable within the data set ever contained less than 153 observations. In
fact, only three of the variables ever dipped below 195 individual observations--and still,
much of the analysis calls for more data. This reality only brings about additional nuance
and unforeseen complications as there exists only a handful of always unfavorable
solutions: add more variables, include more countries, or measure more years. Yet,
adding more variables would increase the potential for collinearity--a problem that would
only bias efficiency estimates and unintentionally increase standard deviations. Similarly,
measuring over a longer time period would be equally difficult because of the lack of
data. In almost all scenarios, if data is not available from 2000 to 2017, there is little
chance it will be available from 1980 to 2000. Lastly, including more countries would
draw attention back to the fundamental requirement of only measuring countries
comparable in likeness. Additionally, this impractical solution would only augment the
difficulties of assessing EHR implementation and environmental variables within the
country which allow each healthcare system to be financed, operated, and improved.
The study of international healthcare efficiency appears to be fighting an uphill
battle on many different fronts. From understanding new technological implementation
standards to developing and defining standards for healthcare efficiency to locating and
analyzing large amounts of data that arrive at statistically significant findings, there
seems to exist no limit on the number of obstacles healthcare researchers and
professionals must overcome in order to arrive at meaningful conclusions. Even preexisting analyses to use as a basis for comparison are almost entirely outdated or
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impossible to find. Still, insightful research in any and all areas of healthcare remains
absolutely necessary in the coming years and decades in order to overcome future health
challenges and dissipate some of the nuance surrounding some of healthcare’s most
convoluted spheres. In the following section, some of this nuance is tackled head-on by
outlining specific EHR implementation histories and outcomes for 5 of the 15 countries
under consideration.
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Chapter Six: Case Studies by Country
As evidenced by the data measured and analyzed in the previous chapter, each of
the 15 countries included in this study demonstrate varying levels of increasing or
decreasing technical efficiency within their respective healthcare systems. The majority
of these countries actually show indeterminate results regarding their healthcare systems’
gains and losses in efficiency as the result of implementation and utilization of EHRs and
HIE, proving the efficacy and future of these technologies somewhat inconclusive.
However, one thing is certain: each nation employs this technology differently.
Some countries began experimenting with the foundational basics of an EHR
early on by incentivizing their patients to access and update their medical information
through the internet. Others still face challenges in implementing these technologies due
to issues with interoperability, security concerns, and decentralized healthcare systems.
These country-to-country variations are to be expected in international comparisons, but
it remains important to highlight these differences to show how this technology is being
employed differently to yield effective or ineffective results. Five countries--Canada,
Japan, France, the United Kingdom, and the United States--are chosen from the
comparison not only to serve as representations of the group as a whole, but also to
provide distinct examples of these varying levels of EHR implementation. In addition to
their own distinct healthcare systems, each of these countries possesses a unique history
of EHR adoption, utilization, and effectiveness. An understanding of these characteristics
may help countries better identify how to implement these health records more
efficiently--or not at all--both now and in the future.
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Case Study 1: Canada
When thinking of Canada’s contributions to the world, it seems difficult to stray
away from popular topics like maple syrup, hockey, and Tim Hortons--but in the realm of
healthcare, Canada has quite a bit to offer healthcare researchers. The nation is
representative of many of the countries utilized within this analysis and uniquely
highlights both an interesting healthcare system and history of EHR use. Canadian
healthcare was founded and designed so that “all insured persons have access to
medically necessary hospital and physician services on a prepaid basis,” (Government of
Canada, 2011). Similar to the United States, this insurance system is financed both
publicly and privately. An estimated 69.8% of total health spending in Canada comes
from public sources (CIHI, 2016). These expenses are funded primarily through the
federal government’s contributions to the provinces and territories on a per capita basis.
Nevertheless, private insurance is quite common as well and nearly ⅔ of Canadians
maintain coverage for services typically excluded from public reimbursement like vision,
dental, and rehabilitative care (Canadian Life and Health Insurance Association, 2015).
Canada’s experiences with electronic health records began at the turn of the
century. In an effort to improve both the patient experience and unlock sources of value
for the health system, the Canadian government made the decision in 2001 to create
Canada Health Infoway Inc. (Infoway). This not-for-profit private corporation describes
its role as that of a “strategic investor” to accelerate the development of electronic health
records across the country. Infoway was specifically charged with developing and
implementing several types of digital health solutions including laboratory information
systems, diagnostic imaging and drug information systems, and interoperable electronic
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health registries and records. By March 31st, 2009, Infoway had spent nearly $615
million and committed another $614 million (approximately $1.2 billion in total) to the
EHR initiative (Office of the Auditor General of Canada, 2010). Fortunately, the venture
has proven fruitful for the Canadian government. A 2009 report from the Auditor General
of Canada found that Infoway’s EHR initiative showed “due regard” for taxpayers’
money and outlined a number of pathways to continue to improve the program. Even
more indicative of Infoway’s success was a recent study done to test the initiative’s
effectiveness. This study by PricewaterCoopers LLC found that, between 2006 and 2012,
the increased use of electronic medical health records saved $1.3 billion--nearly $800
million in administrative efficiencies and $584 million in health system benefits
(avoiding duplicate diagnostic tests, improving chronic disease management, improving
communication across providers, etc.) (CBC News, 2013).
Canada Health Infoway’s success is certainly praiseworthy--and some countries
may find its success deserving of use as a blueprint for the development of other EHR
systems--but there remains no national strategy for implementing EHRs. Instead, each
province's systems remain somewhat divided in collecting data and sharing it
interoperably throughout the country. And while EHR use more than doubled from 2006
to 2012 (CBC News, 2013), by 2014 only 42% of general practitioners reported using
EHRs to enter and retrieve clinical notes and 38% still claimed to use a combination of
paper and electronic charts. In the same survey, 87% of general practitioners reported that
their patients do not have access to their own personal health record and only 6% of
patients have the ability to request appointments online (Allin, n.d.). Compiled with the
fact that hospital setting implementation of EHRs remains abysmally low, it appears as

Pfaehler 70
though Canada is still struggling with its fair share of problems with health information
exchange implementation. This may be evidenced by Canada’s overall efficiency score of
0.633, ranking second to worst behind the Netherlands of the ten countries displaying
overall scores. Even taking into consideration the fact that Canada only exhibited scores
for four of the eighteen years, it is disappointing that the country only showed a 0.007
increase in efficiency from the year 2005 to 2017. Nevertheless, given the country’s
recent history of financial success utilizing HIE, Canada provides an optimistic outlook
for the future of EHR development and certainly has more to provide international
healthcare researchers than a tasty coffee and doughnut.
Case Study 2: Japan
With an incredibly developed and industrialized society as well as an increasingly
aging population of more than 127 million people, Japan provides one of the most
prudent healthcare system examples in the world. The Japanese possess what is known as
a Statutory Health Insurance System (SHIS) that provides universal primary coverage
and comprises more than 3,400 noncompeting public, quasi-public, and employer-based
insurers. The national government sets provider fees and subsidizes care through general
tax revenue and insurance contributions. Primary care is typically provided in private
nonprofit hospitals which account for approximately 80% of beds while public hospitals
round out the other 20% (Matsuda, n.d.). This combination of funding and treatment
options have boded well for the nation. The government has long boasted the
affordability and first-class nature of its healthcare system. In fact, Japan has consistently
remained atop the world rankings with its high life expectancy. In 2017, the OECD
ranked the average lifespan in Japan first in the world at 84.2 years. This area of care
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delivery is where Japan’s future in healthcare becomes truly intriguing--and, frankly,
worrisome.
In addition to the country’s excellent life expectancy, Japan’s healthcare system is
also regarded as one of the world’s most favorable because it maintains rigorous price
controls on cost of care, medications, and surgical procedures to protect its citizens. The
country upholds a strict requirement that hospitals remain nonprofitable, so the majority
of public hospitals continually operate at a deficit. Some might see little problem with
this arrangement, but Japan’s increasingly aging population appears to be placing the
nation’s already strained system under more pressure than ever. In an article from The
Japan Times, one writer highlights how Japan ranks third highest in health spending as a
percentage of GDP, trailing only the United States and Switzerland. Quoting Yusuke
Tsugawa, a physician and research associate at Harvard University specializing in health
care economics, the article adds that “...while the government controls the cost of medical
goods and services, it doesn’t control the volume of the services provided...This has
fostered a culture in Japan of patients seeking more care than necessary because access is
unlimited,” (Otake, 2017). Unfortunately, as the Japanese population continues to grow
and the nearly 26% of its citizens aged 65 or older grows to nearly 33% by 2050 (ILC
Japan, 2013), healthcare system sustainability is only going to grow increasingly more
uncertain.
One might certainly find Japan’s healthcare worries a prime opportunity to
implement innovative technology like EHRs and HIE to help solve this potentially costly
development. In fact, looking to get ahead of problems looming on the horizon, Japan
initially attempted EHR adoption in the latter half of the 1990s, but it was not until 2002
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that the EHRs became more widespread (Tanaka, 2007). EHRs have been developed and
experimented in select areas in the years following this movement, but since momentum
faltered around 2006 a national system has yet to be established or implemented on a
comprehensive scale. Unsurprisingly, interoperability between providers at the local and
regional levels was also overlooked. The government maintains that experiments are
currently underway to make HIE available to patients and providers via cloud computing
which would give patients access to features like unique identifier numbers and Social
Security and Tax Number Systems. Initiated in 2016, these efforts were scheduled to be
phased into healthcare delivery networks by 2018 (Matsuda, n.d.). Supporters of EHR
systems may find this news promising, but the reality remains that Japan is very farremoved from meaningful health information exchange.
The turbulent nature of Japan’s EHR history and the lack of information regarding
the country’s healthcare efficiency score lends little information as to why Japan
continues to demonstrate interest in reviving its once-failed healthcare technology. After
all, their attempts appear more like efforts to resuscitate a lifeless EHR program than they
do pursuits to bolster an already effective healthcare tool--which begs the question why
Japan has continued to invest in EHR and HIE? This persistent, albeit lackluster,
endeavor could exist thanks to techno-optimist sentiment in one of the world’s most
technologically advanced countries. Perhaps these actions may be the result of the
foresight of policy experts and medical professionals who visualize the looming threat of
population aging on the horizon. Or, as some researchers claim, this may be due to
Japan’s historic compulsion to maintain the “status quo” and avoid the embarrassment of
failing to “maintain the high standards of medicine now in use in Japan,” (Yoshihara,
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1998). Justification for each of these speculative reasons remains somewhat unfounded;
yet, it remains clear that EHR and HIE technologies are tools that countries like Canada
and Japan continue to invest in despite their questionable practicalities and benefits.
Case Study 3: France
It is nearly impossible to have a conversation about electronic health records and
health information exchange without discussing France. The country first began
experimentation with an EHR in 1998 when it launched the Carte Vitale, a health
insurance card intended to allow patients to settle directly with the medical arm of the
social insurance system (Brieu, n.d.). Since then, the country has led the charge
internationally in health information exchange by attempting to expand upon its original
Carte Vitale with the Carte Vitale 2--a similar smart card carrying a picture for
identification and the ability to store electronic documents. Even more impressive was
the country’s lofty goal to expand computer-based medical efforts in 2004 with its
“Dossier Médical Personnel, DMP” (known as the “Dossier Médical Partagé” since
2015) which is a “digital health booklet that stores and secures your health
information...It allows you to share them with the health professionals of your choice,
who need to care for you” (DMP France, 2020). The DMP was created with the hope that
an EHR system would help increase communication and transparency and improve
overall quality of care, but it was not long until France ran into problems with
longitudinal paper records and patient security. The project looked defeated when the
government failed to make the DMP fully operational by its goal of 2007, but soon
gained new life when the French national legislature and Ministry of Health relaunched
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the project with full support in 2011 (Stone, 2014). The system has since grown in
operational ability and approval.
Admittedly, EHR adoption rates in France were only measured at 67% for
physicians (Stone, 2014). However, the capabilities of the DMP make it one of the most
adept in the world. With the Dossier Médical Partagé, patients not only have access to
their own unique electronic identifier number, the ability to make appointments easily
online, and a personalized patient portal, but they also have the ability to allow any health
professional or facility access to their medical record for consultancy and treatment of
any kind. This level of unparalleled interoperability is ensured through the chip on each
patient’s Carte Vitale health card and endorsed thanks to France’s centralized top-down
driven governmental system.
France has a stronger hold on privacy laws than most other nations which allows
the country to bypass rules and regulations that would normally overemphasize privacy
concerns (Stone, 2014). This governmental structure provides the perfect foundation for
future EHR systems to successfully connect and operate with advanced capabilities like
increased interoperability and clinical decision support (CDS). Interoperability between
health and social care professionals has not yet been permitted (Durand-Zaleski, n.d.), but
this level of exchange of information is unheard of elsewhere in the world and appears to
have yielded dividends for France’s healthcare efficiency as of late. This is evidenced by
the country’s 0.091 increase in efficiency over the eighteen year period and the 0.115
increase from 2015 to 2016, in particular. While these increases have only been
witnessed recently, this development is promising for the future of EHR in France and
elsewhere throughout the world. France’s recent success in EHR gains and continued
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pursuit of HIE diversification exemplifies why other nations like the United States should
look to France for help in creating more robust, adaptable, and interoperable HIE systems
for the future.
Case Study 4: United Kingdom
Created in 1948 following the end of World War II, the United Kingdom’s
National Health Service (NHS) represents the world’s oldest universal healthcare system
(Brain, n.d.). Since it was founded, the NHS has prided itself on providing free coverage
at the point of need to all eligible citizens. These services are traditionally financed
through taxes, and citizens have experienced increased taxation for health services since
the 1980s as health expenditure has continued to trend upward. Today, the NHS promises
more information, resources, and healthcare employees for patients while continuing to
combat long wait times, high accident and emergency (A&E) department costs, and a
fast-aging population.
The United Kingdom’s history with EHRs is equally as interesting as it is
complicated. In 2002, the UK government launched the development of the NPfIT
otherwise known as NHS Care Records Service. This program was intended to deliver an
EHR system that could store and share patient records from across the UK. However,
there were soon numerous problems relating to poor user accessibility, failures in
addressing patient confidentiality, overambitious timescales, and enormous cost overruns.
In 2008, the Summary Care Record (SCR) was introduced and headed by the NHS with
the intention of its use as an EHR in emergency or out-of-hours care settings. By 2011,
the NPfIT was dismantled almost entirely and the SCR was named the focus of the NHS.
However, shortly after, the SCR also dealt with similar shortcomings and the UK
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abandoned their pursuit of a national EHR and instead shifted focus from HIE
implementation on a national scale to management and use by individual general
practitioners (GPs).
Since April 2015, these GP practices have been obligated to offer patients the
option to book appointments and request prescriptions online. These requirements were
expanded in 2018 to include offering patients information about their diagnoses,
medications, treatments, immunizations, and test results. An NHS App was even
developed and rolled out in January 2019 (NHS England, 2019). The app is designed to
give patients an additional resource to access their medical records, book appointments,
refill prescriptions, and manage their long-term conditions (Australian Digital Health
Agency, n.d.). Despite these successes, SCR records are never linked between GPs or
other providers and the UK still lags far behind their goal of reaching digital maturity for
their patients. NHS patients continue to find themselves unable to secure digital copies of
their health records, and while the NHS aimed to make primary, urgent, and emergency
services paperless by 2018--and all other NHS services paperless by 2020--the general
consensus appears to be that these targets are still years away (Thorlby, n.d.).
Analogous to the struggle of implementing an effective EHR and making all NHS
services paperless is the United Kingdom’s shortcoming in failing to maintain a sufficient
longitudinal record of health data. This information deficiency--particularly within the
OECD iLibrary Data Warehouse--is what makes the UK one of five countries within the
analysis that produces no efficiency scores for any of the eighteen separate time periods.
For this reason and others previously outlined, future plans for the establishment of an
interoperable EHR system in the UK appear rather bleak. However, the NHS App and its
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success in offering patients useful electronic resources is yet another testament to the
advantages of different forms of health information technology and exchange.
Case Study 5: United States
For the longest time, the United States healthcare system has been one of the most
well-known and frequently discussed care networks in the world--for all of the wrong
reasons. Healthcare coverage in the United States has lived in infamy for decades for its
hyper-privatization, severe disparities in health delivery, and abysmal rates of uninsured
individuals. Even more abhorrent than these disappointing attributes is the grim reality
that the country has continually maintained exceptionally high healthcare costs without
experiencing comparable gains in population health. One might even consider this the
legacy of the United States healthcare system: spend more and get less in return.
With the emergence of the internet and web-based software at the turn of the
century, many within the government believed technological innovation could pose a
potential solution to some of the dilemmas plaguing the healthcare system. During
President George W. Bush’s time in the Oval Office, the budget for healthcare IT projects
doubled and a new sub-cabinet position of National Health Information Coordinator was
created (University of Scranton, n.d.). At the start of President Barack Obama’s tenure in
the White House, an even more progressive move towards the adoption of healthcare
technology was proposed with the American Recovery and Reinvestment Act (ARRA)
and its subtitle, the Health Information Technology for Economic and Clinical Health
(HITECH) Act. Signed into law in February of 2009, both of these laws were enacted to
“promote the adoption and meaningful use of health information technology...and address
the privacy and security concerns associated with the electronic transmission of health
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information,” (U.S. Department of Health and Human Services, 2017). A portion of this
legislation was dedicated to strengthening the criminal enforcement of HIPAA (Health
Insurance Portability and Accountability Act) passed by Congress in 1996, but the
HITECH Act was equally dedicated to constructing an electronic health record system
and encouraging industry-wide adoption within the decade. Both the ARRA and
HITECH Act led to significant investments in HIE--more than $30 billion--and
established financial incentives for physicians and hospitals to adopt EHR systems under
what is now known as the EHR Incentive Program (The Commonwealth Fund, n.d.).
A well-established and high-functioning electronic health record in the United
States was hypothesized to lead to a number of improvements in the healthcare system-not only from the perspective of cost, but also of quality of care delivered to each and
every patient. The ability to access and update medical information remotely made an
electronic method of keeping records very appealing and ultimately justified both
physicians’ decisions to invest in EHRs to improve their practice and the government’s
decision to subsidize some of these implementation costs. Unique to other countries
examined, the United States went a step further to ensure that professionals choosing to
adopt these systems implemented them in an effective and economical manner. Thus, the
concept of “Meaningful Use” was established under the EHR Incentive Program with
three different Meaningful Use stages: Meaningful Use Stage 1, Meaningful Use Stage 2,
and Meaningful Use Stage 3.
The first of these stages includes meeting 14 to 15 out of 20 core requirements
and 5 out of 10 menu requirements such as the ability to record demographics, use
computerized order entry (COE) for medication orders, send reminders to patients for
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preventative/follow-up care, and implement simple clinical decision support (CDS)
suggestions (HealthIT, 2012). The second stage of Meaningful Use expanded upon Stage
1 to encourage improved functionality of EHR systems--that is, meeting more than 15
core requirements and more than 5 menu requirements. In October 2015, the Centers for
Medicare and Medicaid Services (CMS) released requirements for achieving Stage 3 of
Meaningful Use, which focused on EHR systems improving health outcomes and care
delivery by 2018 (CDC, 2019). While researchers have yet to receive results on this data,
it is clear that EHR adoption in the United States has drastically increased since the
beginning of its implementation. As of 2015, 84% of physicians use some form of EHR
system and three out of four hospitals (76%) have adopted some basic form of EHR
system. This represents an eightfold increase in EHR implementation since 2008 (The
Commonwealth Fund, n.d.). The ARRA, HITECH Act, and EHR Incentive Program
were all designed to gradually raise the threshold for EHR implementation and
functionality across the United States. Up to this point, these initiatives seem to be
achieving their goal in that regard.
The differences between continued improvement in the United States; partial
success in Canada; and ranges of ineffective implementation in countries like Japan and
the United Kingdom depend on variables such as history of EHR use; current level of
implementation; outlook for the future; and much more. While Canada has saved
hundreds of millions with initial EHR systems, their implementation rates among
physicians and hospitals remain considerably lower than those in the US. More
importantly, where countries like Japan and the United Kingdom appear rather content in
maintaining the health information systems they currently have in place, the United
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States is continuously demanding more from EHR systems and improving the
functionality of the technology as a result. Woefully, our analysis is unable to corroborate
this assessment due to missing efficiency scores of the United States’ healthcare system
from 2011 to 2017. Therefore, whether or not the US has succeeded in increasing the
quality of care, health outcomes, and efficiency of their healthcare system through the use
of EHR and HIE remains to be determined.
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Chapter Seven: Conclusion
Ephemeralization is a term intimately linked with the concept of efficiency and it
is especially relevant in the context of our increasingly modernizing world. This term,
coined by R. Buckminster Fuller, refers to the ability of technological advancement to do
“more and more with less and less until eventually you can do everything with nothing,”
(Fuller, 1938). Fuller’s vision was that ephemeralization could continue to rectify everincreasing standards of living with an ever-growing population despite a finite supply of
resources. This subsidiary of efficiency may seem like nothing but a pipe dream. After
all, basic concepts as elementary as the laws of conservation of energy and mass state
very clearly that something cannot be created out of nothing. However, attaining higher
levels of efficiency within our daily lives and governmental systems is absolutely
imperative as populations continue to grow and societies continue to develop.
As with any large transformative process, some sectors of life and government
have already begun to take the leap of increasing their efficiency by adopting
increasingly dynamic methods of production. Food systems have developed farming and
agricultural methods that grow produce and livestock bigger and faster and transportation
systems have evolved to move more people over longer distances in shorter amounts of
time than ever before. Healthcare systems have likewise adapted to changes in population
and technology growth. Innovations such as artificial intelligence, virtual reality
simulations, and three-dimensional printers are just a handful of a seemingly endless
number of cutting-edge technologies that have helped healthcare professionals today
improve their quality of care and do more with less--but can innovations like these alone
slow the tide of much greater problems soon to be brought about by the epidemiological
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shift of our modern era? This transition from treating patients with one-time, acute
illnesses to dealing with older, more obese, and increasingly immunocompromised
victims of chronic disease has already placed a heightened strain on healthcare systems
around the world that will only intensify as time passes. It is precisely for this reason that
new technological advancements in healthcare delivery should be both broadly explored
and meticulously assessed.
One innovation in particular--the electronic health record (EHR)--shows
promising signs of the ability to improve healthcare delivery and thus increase entire
health system efficiency. Electronic health records are defined as ‘a longitudinal
electronic record of patient health information generated by one or more encounters in
any care delivery setting. Included in this information are patient demographics, progress
notes, problems, medications, vital signs, past medical history, immunizations, laboratory
data, and radiology reports,’ (Menachemi, 2011, p. 48). The three functionalities that
make EHRs so attractive as a potential solution to health system inefficiency and rising
healthcare costs are clinical decision support (CDS) tools, computerized physician order
entry (CPOE) systems, and health information exchange (HIE) capabilities (Menachemi,
2011). Yet, despite these dynamic functions, EHRs are also frequently critiqued by those
skeptical of their practicality and efficacy in healthcare settings because they can be
expensive, difficult to implement effectively, and even lead to burnout among healthcare
workers (Brown, 2019). This contrasting sentiment about the influential nature of EHRs
begs the question whether this recently implemented medical technology has affected the
health system efficiency of countries choosing to implement this tool--and if so, to what
end and extent?
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In order to answer this research question, the idea of efficiency was first defined
in a number of ways. It proved important to identify both a general definition of
efficiency--to produce desired results with little or no waste of time or materials--and
apply this definition more broadly in order to understand the concept of healthcare
efficiency--the extent to which inputs to the health system are used effectively to secure
valued health system goals. After accomplishing this task, this knowledge was used in
coordination with the different terms of allocative and technical efficiency to provide a
naive framework for thinking about healthcare system efficiency. This framework was
then enhanced by explaining the different inputs and outputs under consideration within a
health system as well as highlighting several environmental variables like governmental
constraints, population aging, etc. which help control for potential confounding variables
within any efficiency study. Such a comprehensive framework not only provided an
exemplary foundation for future efficiency studies, but also took into account studies of
efficiency at the international level. Thankfully, this model mitigated many of the
difficulties surrounding the nuance of a fifteen country healthcare efficiency analysis.
Where other blueprints struggle to compensate for the number of differences in
healthcare and governmental policies, the aforementioned framework effectively
compared any and every country so long as they were determined to be reasonably alike.
Having established this comprehensive framework for modeling international
healthcare system efficiency, all that remained of the study was to decide upon each of
the fifteen countries under consideration, select the appropriate analytical method for
determining healthcare efficiency scores for each country, and effectively calculate and
interpret the analysis’ results. The first of these undertakings was rather easy to complete
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as each of the fifteen countries chosen is comparatively modernized and industrialized
with a health system that is unique, diverse, and rather high functioning. Even more
important was the fact that each of these countries holds membership in the OECD and
continuously updates database profiles which contain countless insights into the
operational capacity of their respective healthcare systems.
Unfortunately, there are countless reasons why completing healthcare efficiency
analyses proves so burdensome. One of the main reasons for this difficulty is the lack of
consensus on which analytical method to utilize to perform such an analysis. Two of the
more favorable methods that have grown in popularity over the last several decades are
known as Data Envelopment Analysis (DEA) and Stochastic Frontier Analysis (SFA).
Over 400 published applications have used these methods within health care settings over
the past 30 years (Cylus, 2016, p. 99). Both methods see efficiency as a simple
relationship between inputs consumed and outputs produced and assess how effectively a
unit of production, such as a hospital, uses its own inputs, such as staff and drugs, to
produce outputs, such as patients treated. However, where DEA often focuses on
complicated linear programming methods that place weights on certain inputs and
outputs, SFA uses statistical regression methods that combine all variables into a single
aggregate measure. SFA measures relationships between variables in ways that are
frequently regarded as more user-friendly and easily understandable. This fact--compiled
with the reality that online resources and research professionals were more easily
available to assist in a study using a SFA approach--made the decision to utilize SFA a
rather easy decision.
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Even with the help of online resources and research professionals, completing the
Stochastic Frontier Analysis was assuredly the most difficult portion of the entire
research project. An immense amount of time was consumed to identify reliable
databases, create and organize datasets, and locate individuals to assist in completing the
analysis. The largest of these delays occurred due to a lack of information and resources
available both online and through the university. While there were several individuals
who provided assistance in other areas of the project, few had the expertise to contribute
to a DEA or SFA analysis pertaining to the healthcare sector. In the future, my personal
recommendation for students is to either consider using simpler regression methods in
STATA from the onset of their project or plan on hiring third-party research experts on
platforms such as Upwork for assistance in completing more complex analytical
approaches. Although, even this action may not yield findings considerably more
pragmatic than those previously outlined in Chapter Five.
Ultimately, almost all of these actions--defining efficiency, contextualizing this
understanding of efficiency within the healthcare sector, highlighting the difficulties of
international country comparisons, explaining analytical approaches to healthcare
efficiency analysis, and performing a Stochastic Frontier Analysis--produced little
conclusive data in determining the impact EHRs and HIE have had on international
healthcare system efficiency. Fortunately, Table 5.1 and Table 5.2 provide some
practicable information on the effectiveness of certain input variables to the hospital
sector--most notably, the positive effect of increasing the number of physicians employed
in hospitals. Perhaps the most useful findings relating to the current state of EHR and
HIE use are located within Table 5.5, which provides the initial dates of EHR
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implementation and an index score for each respective country as well as each EHR
implementation’s respective names. This data, along with a number of other findings, is
certainly useful information that could contribute to the advancement of future studies.
More importantly, it is imperative to emphasize the significance of this study even
without validating its findings--regardless of how limited they may be. The reality of all
international healthcare analysis is that researchers are already fighting an uphill battle
when they make the decision to attempt to study such complex and varying systems. As
proven by the explanations provided in this research project, performing efficiency
studies of any degree can be a complicated process, but even more so in the context of
healthcare--and especially at the international level. More complex methods of analysis
using statistical programming like DEA only further complicate these matters and make
arriving at results as well as statistical significance even more difficult to determine. Even
when data is readily available, such a challenging field of study requires highly
specialized and knowledgeable professionals to make sense of such information.
Nevertheless, the truth remains that the nuance surrounding the evaluation of healthcare
systems and their efficiency does not disappear despite the seemingly insurmountable
obstacle of arriving at conclusive results. Instead, national and global researchers alike
should continue to push forward to develop new and improved metrics and measures in
order to find solutions to these increasingly complex problems. While this analysis may
fall short in determining the abiding effects of international EHR and HIE
implementation today, perhaps the information presented can prove helpful in
determining the outlook of such technology for the future.
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Admittedly, this data analysis seems to raise more questions about both the longterm efficacy of EHRs and the feasibility of performing international healthcare
efficiency analyses than it does affirm optimistic sentiments about health information
technology as a whole. However, this ambiguous conclusion seems quite poetically just
for a topic surrounded by such immense debate and uncertainty. With each and every
passing week, new information is brought forth deeming EHRs the savior of healthcare
efficiency, the bane of every physician’s existence, and everything in between. Despite
this extraordinary ambivalence, it is clear that--for one reason or another--EHRs and HIE
are absolutely here to stay for the foreseeable future. After all, the quest for efficiency is a
pursuit that has consumed the thoughts of governments around the world for generations;
and while the concept of ephemeralization might be too utopic for some world leaders to
bear, the need for healthcare systems to improve their quality of care for patients who
continue to grow older, more obese, and increasingly afflicted with chronic diseases is an
obligation that will not disappear anytime soon.
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Appendix
Entry 1: STATA Do File Command
*Provided by Upwork Freelancer Deni Mazrekaj*
***STOCHASTIC FRONTIER ANALYSIS***
clear
import excel "/Users/davidpfaehler/Desktop/Thesis - Extended Data Sheet
> STATA.xlsx", sheet("Efficiency") firstrow
drop tdum*
**FIRST OUTPUT**
gen logov1 = log(ov1)
global y logov1
global x iv1 iv2 iv3 iv4
global z ev1 ev2 ev3 ev4 ev5 ev6 ev7 ev8 ev9 ev10 ev11 ev12
*Remove Missing observations*
/*For a cleaner analysis you can drop the missings, but the problem of convergence will
occur due to a small sample*/
*drop if
missing(logov1,ov2,iv1,iv2,iv3,iv4,ev1,ev2,ev3,ev4,ev5,ev6,ev7,ev8,ev9,ev10,ev11,ev12
)
*Cross-sectional Stochastic Frontier Analysis*
sfcross $y $x, distribution(tnormal)
/*overall efficiency*/
predict effcross1, bc
/*Efficiency by country*/
bys country: egen effbycountry1 = mean(effcross1)
tab effbycountry1 country
/*Efficiency by country and year*/
br country year effcross1
/*effect of environmental variables:
Ideally you would do this in a single stage, however problems of converge occur, so it's
in two stages here*/
reg effcross1 $z
*Panel Stochastic Frontier analysis
/*For a more correct analysis, a panel model should be performed as below,
however convergence problems occur as the data is not suitable for this analysis*/
*xtset country year
*sfpanel $y $x, distribution(tnormal)
*predict effpanel1, bc
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*sum effpanel1
*reg effpanel1 $z
**SECOND OUTPUT**
gen logov2 = log(ov2)
global y logov2
*Cross-sectional Stochastic Frontier Analysis*
sfcross $y $x, distribution(tnormal)
/*overall efficiency*/
predict effcross2, bc
/*Efficiency by country*/
bys country: egen effbycountry2 = mean(effcross2)
tab effbycountry2 country
/*Efficiency by country and year*/
br country year effcross2
/*effect of environmental variables:
Ideally you would do this in a single stage, however problems of converge occur, so it's
in two stages here*/
reg effcross2 $z
*Panel Stochastic Frontier analysis
/*For a more correct analysis, a panel model should be performed as below,
however convergence problems occur as the data is not suitable for this analysis*/
*xtset country year
*sfpanel $y $x, distribution(tnormal)
*predict effpanel2, bc
*sum effpanel2
*reg effpanel2 $z

